>FW339255.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
GATTACG
>FW339225.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGATAT
>FW339223.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGCAATA
>FW339220.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGATGTA
>FW339217.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGATAAC
>FW339215.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCGCTTT
>FW339185.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATATGCG
>FW339172.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAGCGGA
>FW338925.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTTTTT
>FW338924.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTTTT
>FW338923.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAATTTT
>FW338922.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAATTT
>FW338921.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAATT
>FW338920.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAT
>FW338912.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTT
>FW338911.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCC
>FW338910.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AAAAAAA
>FW338828.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTTC
>FW338827.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTTCC
>FW338826.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTTCCC
>FW338825.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTTCCCC
>FW338824.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TTCCCCC
>FW338823.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
TCCCCCC
>FW338822.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CGGGGGG
>FW338821.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCGGGGG
>FW338820.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCGGGG
>FW338819.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCGGG
>FW338818.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCGG
>FW338817.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
CCCCCCG
>FW338804.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
GGGGGGG
>FW338771.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
ATTCCGG
>FW338770.1 Targeted Whole Genome Amplification Method for Identification of Pathogens
AATTCCG
>FW341633.1 Compositions of TLR Ligands and Antivirals
NTTGTGT
>FW341629.1 Compositions of TLR Ligands and Antivirals
NTTGTGT
>FW341628.1 Compositions of TLR Ligands and Antivirals
NTTGTGT
>FW341627.1 Compositions of TLR Ligands and Antivirals
GTTGTNT
>FW341626.1 Compositions of TLR Ligands and Antivirals
NTTGTGT
>FW341625.1 Compositions of TLR Ligands and Antivirals
GTTNTGT
>FW341624.1 Compositions of TLR Ligands and Antivirals
NTTNTNT
>FW341062.1 CpG Oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
GNCGNTN
>FW341061.1 CpG Oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
GNCGNTN
>FW341060.1 CpG Oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity
GNCGTTN
>HC872563.1 Sequence 3719 from Patent WO2010054007
GGTCTCN
>HC878536.1 Sequence 39 from Patent WO2010036979
ACCATGT
>HC878535.1 Sequence 38 from Patent WO2010036979
ACCATGA
>HC878534.1 Sequence 37 from Patent WO2010036979
GACATGA
>HC878533.1 Sequence 36 from Patent WO2010036979
AAGATGG
>HC878532.1 Sequence 35 from Patent WO2010036979
ACGATGA
>HC878531.1 Sequence 34 from Patent WO2010036979
AAGATGT
>HC878530.1 Sequence 33 from Patent WO2010036979
ACCATGT
>HC878529.1 Sequence 32 from Patent WO2010036979
ACCATGG
>FW331719.1 DETECTING NUCLEIC ACIDS
CGAACGA
>FW331683.1 DETECTING NUCLEIC ACIDS
TATCCTA
>FW331628.1 DETECTING NUCLEIC ACIDS
GCAATGC
>HC767973.1 Sequence 107 from Patent WO2010049156
GCGTGGT
>HC767933.1 Sequence 67 from Patent WO2010049156
GCACGTC
>HC767926.1 Sequence 60 from Patent WO2010049156
GAAGCCG
>HC767883.1 Sequence 17 from Patent WO2010049156
GCACGTC
>HC731223.1 Sequence 3 from Patent WO2010043243
CCCTAAA
>HC730277.1 Sequence 17 from Patent EP2179737
GTTCGTC
>HC689066.1 Sequence 54 from Patent WO2010037539
GGTTTGG
>HC679349.1 Sequence 48 from Patent WO2010036978
ACCATGT
>HC679348.1 Sequence 47 from Patent WO2010036978
ACCATGA
>HC679347.1 Sequence 46 from Patent WO2010036978
GACATGA
>HC679346.1 Sequence 45 from Patent WO2010036978
AAGATGG
>HC679345.1 Sequence 44 from Patent WO2010036978
ACGATGA
>HC679344.1 Sequence 43 from Patent WO2010036978
AAGATGT
>HC679343.1 Sequence 42 from Patent WO2010036978
ACCATGT
>HC679342.1 Sequence 41 from Patent WO2010036978
ACCATGG
>HC679297.1 Sequence 36 from Patent WO2010036976
ACCATGT
>HC679296.1 Sequence 35 from Patent WO2010036976
ACCATGA
>HC679295.1 Sequence 34 from Patent WO2010036976
GACATGA
>HC679294.1 Sequence 33 from Patent WO2010036976
AAGATGG
>HC679293.1 Sequence 32 from Patent WO2010036976
ACGATGA
>HC679292.1 Sequence 31 from Patent WO2010036976
AAGATGT
>HC679291.1 Sequence 30 from Patent WO2010036976
ACCATGT
>HC679290.1 Sequence 29 from Patent WO2010036976
ACCATGG
>HC504577.1 Sequence 4 from Patent WO2010037593
TATAAAA
>HC504576.1 Sequence 3 from Patent WO2010037593
GGGCGCC
>HC502215.1 Sequence 27 from Patent EP2175022
AAAGGGG
>HC502214.1 Sequence 26 from Patent EP2175022
TTTAAAG
>HC502213.1 Sequence 25 from Patent EP2175022
GGGAAAA
>HC502212.1 Sequence 24 from Patent EP2175022
AAAAGGG
>HC502211.1 Sequence 23 from Patent EP2175022
GGGAAAG
>HC502210.1 Sequence 22 from Patent EP2175022
AAAAAAC
>HC502209.1 Sequence 21 from Patent EP2175022
AAAAAAA
>HC502208.1 Sequence 20 from Patent EP2175022
AAAAAAG
>HC502207.1 Sequence 19 from Patent EP2175022
TCCTGAT
>HC502206.1 Sequence 18 from Patent EP2175022
GCGAGTT
>HC502205.1 Sequence 17 from Patent EP2175022
CTTAGGC
>HC502204.1 Sequence 16 from Patent EP2175022
GGATTTA
>HC502202.1 Sequence 14 from Patent EP2175022
TTTAAAT
>HC502201.1 Sequence 13 from Patent EP2175022
TTTAAAC
>HC502200.1 Sequence 12 from Patent EP2175022
GGGTTTT
>HC502199.1 Sequence 11 from Patent EP2175022
GGGTTTA
>HC502198.1 Sequence 10 from Patent EP2175022
GGGCCCC
>HC502197.1 Sequence 9 from Patent EP2175022
GGGAAAC
>HC502196.1 Sequence 8 from Patent EP2175022
AAATTTT
>HC502195.1 Sequence 7 from Patent EP2175022
AAATTTA
>HC502194.1 Sequence 6 from Patent EP2175022
AAAAAAC
>FW303109.1 Anti-C35 Antibodies for Treating Cancer
GGTCACC
>FW300338.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNGCC
>FW300337.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNACG
>FW300318.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGANGGC
>FW300312.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNGAG
>FW300278.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNTGC
>FW300247.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
ACGNCCC
>FW300243.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GAGNCCC
>FW300218.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNCCC
>FW300205.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNAGG
>FW300191.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNCCC
>FW300177.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANCCC
>FW300176.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNGGA
>FW300165.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNCCA
>FW300130.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNGCC
>FW300081.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNCGG
>FW300065.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNTGC
>FW300000.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNGCC
>FW299971.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGCNCCC
>FW299928.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNCCC
>FW299915.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNCGC
>FW299869.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCANCGC
>FW299850.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNACC
>FW299849.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNCGG
>FW299843.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNGCC
>FW299834.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CTGNCCC
>FW299828.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNCGC
>FW299826.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNGGC
>FW299800.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNACC
>FW299793.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNCCC
>FW299784.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCCNCGC
>FW299756.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNGCG
>FW299746.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNCCG
>FW299743.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNGGC
>FW299735.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANCGG
>FW299730.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNCAG
>FW299715.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNGGG
>FW299701.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNGCA
>FW299683.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGANCCC
>FW299673.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNGCC
>FW299649.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNCCC
>FW299646.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNGAC
>FW299630.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNGCG
>HC488026.1 Sequence 45 from Patent WO2010033229
GAAGAGC
>HC488025.1 Sequence 44 from Patent WO2010033229
GCTCTTC
>HC486651.1 Sequence 271 from Patent WO2010033237
GAAGAGC
>HC486382.1 Sequence 2 from Patent WO2010033237
GCTCTTC
>HC492634.1 Sequence 81 from Patent WO2010031068
AAGGAGG
>HC492633.1 Sequence 80 from Patent WO2010031068
AGGAGGT
>HC492520.1 Sequence 81 from Patent WO2010031076
AAGGAGG
>HC492519.1 Sequence 80 from Patent WO2010031076
AGGAGGT
>HC492150.1 Sequence 81 from Patent WO2010031079
AAGGAGG
>HC492149.1 Sequence 80 from Patent WO2010031079
AGGAGGT
>HC491994.1 Sequence 81 from Patent WO2010031062
AAGGAGG
>HC491993.1 Sequence 80 from Patent WO2010031062
AGGAGGT
>HC491596.1 Sequence 81 from Patent WO2010031077
AAGGAGG
>HC491595.1 Sequence 80 from Patent WO2010031077
AGGAGGT
>HC488161.1 Sequence 180 from Patent WO2010033229
GCTCTTC
>FV530894.1 DNA molecules and methods
GTTGTGG
>FV522582.1 SYSTEM AND METHOD FOR DETECTING A GENE MUTANT
GTCATCA
>FV522581.1 SYSTEM AND METHOD FOR DETECTING A GENE MUTANT
GTCAACA
>FV522580.1 SYSTEM AND METHOD FOR DETECTING A GENE MUTANT
ATGACTC
>FV522579.1 SYSTEM AND METHOD FOR DETECTING A GENE MUTANT
TTGACTC
>FV519302.1 GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA
CTTTGGC
>FV534024.1 Single-Chain Multivalent Binding Proteins with Effector Function
CTCGAGT
>FV534023.1 Single-Chain Multivalent Binding Proteins with Effector Function
TGATCAG
>HC456392.1 Sequence 60 from Patent WO2010017311
CGGAGTT
>HC456385.1 Sequence 53 from Patent WO2010017311
CGGAGTT
>HC456363.1 Sequence 31 from Patent WO2010017311
GATTTTT
>HC456039.1 Sequence 8 from Patent WO2010019243
GTAAGGA
>HC454178.1 Sequence 60 from Patent WO2010017319
CGGAGTT
>HC454171.1 Sequence 53 from Patent WO2010017319
CGGAGTT
>HC454149.1 Sequence 31 from Patent WO2010017319
GATTTTT
>HC458599.1 Sequence 14 from Patent WO2010019236
GTAAGGA
>HC442436.1 Sequence 60 from Patent WO2008109370
CGGAGTT
>HC442429.1 Sequence 53 from Patent WO2008109370
CGGAGTT
>HC442407.1 Sequence 31 from Patent WO2008109370
GATTTTT
>HC445274.1 Sequence 60 from Patent WO2008109368
CGGAGTT
>HC445267.1 Sequence 53 from Patent WO2008109368
CGGAGTT
>HC445245.1 Sequence 31 from Patent WO2008109368
GATTTTT
>HC443789.1 Sequence 60 from Patent WO2008109369
CGGAGTT
>HC443782.1 Sequence 53 from Patent WO2008109369
CGGAGTT
>HC443760.1 Sequence 31 from Patent WO2008109369
GATTTTT
>FU763487.1 Small Internally segmented interferring RNA
AACGGCC
>FU763485.1 Small Internally segmented interferring RNA
AAGTTCT
>FU762046.1 Antisense Agents Combining Strongly Bound Base-Modified Oligonucleotide and Artificial Nuclease
CCTTCGN
>HC440796.1 Sequence 25 from Patent WO2010012667
TGTAGGA
>HC440793.1 Sequence 22 from Patent WO2010012667
AGCATTA
>HC436282.1 Sequence 141 from Patent EP2151498
ACGTGGC
>HC436251.1 Sequence 110 from Patent EP2151498
AATGATT
>HC436250.1 Sequence 109 from Patent EP2151498
AATCATT
>HC436249.1 Sequence 108 from Patent EP2151498
AATTATT
>HC436248.1 Sequence 107 from Patent EP2151498
AATAATT
>HC319857.1 Sequence 81 from Patent WO2010003007
AAGGAGG
>HC319856.1 Sequence 80 from Patent WO2010003007
AGGAGGT
>S89844.1 XPAC=XP group A complementing {exon 6} [human, mRNA Partial Mutant, 7 nt]
GCCAATT
>S78314.1 transthyretin (TTR) {exon 2} [human, Genomic Mutant, 7 nt]
TCTCGGT
>S75485.1 beta-globin {intron 2 base sustitution at position 654} [human, Genomic Mutant, 7 nt]
AGGTAAT
>S68633.1 APRT=adenine phosphoribosyltransferase {APRT deficiency} [human, Genomic Mutant, 7 nt]
TAGTCTC
>S62216.1 p53 {1 bp deletion at nt 334} [human, Genomic Mutant, 7 nt]
TGGCTTC
>FU249782.1 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
ACGAACA
>FU249779.1 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
TAGCATT
>FU249776.1 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
CACACTC
>FU249773.1 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
ATTTGCA
>FU269615.1 IMMUNOSTIMULATORY ACTIVITY OF IMMUNE MODULATORY OLIGONUCLEOTIDES (IMOtm) CONTAINING DIFFERENT LENGTHS OF PALINDROMIC SEGMENTS
TCNTCNT
>DM475809.1 Matrixmetalloproteinase 9 Gene Selective Expression Inhibitor
TGAGTCA
>DM475807.1 Matrixmetalloproteinase 9 Gene Selective Expression Inhibitor
TGGAATT
>DM475360.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
ATANGAT
>DM475359.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
CAANGTA
>DM475358.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
CAANGGG
>DM475357.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
YNCNTYG
>DM475356.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
ATCCTTA
>DM475355.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
TACNGTG
>DM475354.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
ATGNAAC
>DM475353.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
TAGNTTG
>DM475352.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
TACNTTC
>DM475351.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
ATCNTAT
>DM475350.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
TACNTCG
>DM475349.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
TGCNTTG
>DM475348.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
CACNTCG
>DM475347.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
TACNTTG
>DM475346.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
CGCNTTG
>DM475345.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
CCCNTTG
>DM475344.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
CACNTTG
>DM475343.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
CNCNTNG
>DM475342.1 A novel DNA capable of being amplified by PCR with high selectivity and efficiency
CNANGNG
>HC299721.1 Sequence 181 from Patent WO2008141282
AAAAGGG
>HC299720.1 Sequence 180 from Patent WO2008141282
TGTTTAC
>HC289307.1 Sequence 91 from Patent WO2009151982
TCAATTA
>HC289204.1 Sequence 8 from Patent WO2009151546
GTAAGGA
>HC090629.1 Sequence 4 from Patent EP2123762
AGCCACC
>HC090628.1 Sequence 3 from Patent EP2123762
AGCCGCC
>DM460986.1 METHODS AND PROTEINS FOR THE PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF FOUR SEROTYPES OF DENGUE VIRUS AND OTHER FLAVIVIRUSES
CATGGCA
>BD133077.1 Neuronal stem cell gene
WWCAAWG
>BD105929.1 Leptospira pathogens
TTTGATA
>BD105928.1 Leptospira pathogens
TGTTGGA
>HC053999.1 Sequence 81 from Patent WO2009126894
CTGTCTT
>DM378914.1 Modified pancreas-secreted trypsin inhibitor and DNA encoding it, and use thereof
GAGAGTC
>DM374948.1 Oligonucleotide immobilizing solid phase carrier
ATGGGCC
>HC004626.1 Sequence 198 from Patent WO2009109665
AGCATTA
>HC004621.1 Sequence 193 from Patent WO2009109665
CTAACTC
>HC004620.1 Sequence 192 from Patent WO2009109665
CTACCTC
>HC004614.1 Sequence 186 from Patent WO2009109665
CTACCTC
>HC004608.1 Sequence 180 from Patent WO2009109665
ATGTAGC
>HC004596.1 Sequence 168 from Patent WO2009109665
ATAAGCT
>HC004589.1 Sequence 161 from Patent WO2009109665
GCACTTT
>HC004588.1 Sequence 160 from Patent WO2009109665
CCCCACC
>HC004587.1 Sequence 159 from Patent WO2009109665
CCCAACC
>HC004586.1 Sequence 158 from Patent WO2009109665
GTGCAAT
>HC004585.1 Sequence 157 from Patent WO2009109665
CGAACAA
>HC004584.1 Sequence 156 from Patent WO2009109665
TTTTGAG
>HC004583.1 Sequence 155 from Patent WO2009109665
AGCACTT
>HC004582.1 Sequence 154 from Patent WO2009109665
AGCACTT
>HC004581.1 Sequence 153 from Patent WO2009109665
GTGCAAT
>HC004580.1 Sequence 152 from Patent WO2009109665
TACTTGA
>HC004579.1 Sequence 151 from Patent WO2009109665
GTGCAAT
>HC004578.1 Sequence 150 from Patent WO2009109665
CTACTGA
>HC004577.1 Sequence 149 from Patent WO2009109665
ATGTAGC
>HC004576.1 Sequence 148 from Patent WO2009109665
TGCCAGG
>HC004575.1 Sequence 147 from Patent WO2009109665
ATGTAGC
>HC004574.1 Sequence 146 from Patent WO2009109665
ATAAGCT
>HC004573.1 Sequence 145 from Patent WO2009109665
ACTACAG
>HC004572.1 Sequence 144 from Patent WO2009109665
GCACTTT
>HC004571.1 Sequence 143 from Patent WO2009109665
AATGCAG
>HC004570.1 Sequence 142 from Patent WO2009109665
GCACTTT
>HC004569.1 Sequence 141 from Patent WO2009109665
CATTTCA
>HC004568.1 Sequence 140 from Patent WO2009109665
CAGTATT
>HC004567.1 Sequence 139 from Patent WO2009109665
TTTGCAC
>HC004566.1 Sequence 138 from Patent WO2009109665
GCAAAAC
>HC004565.1 Sequence 137 from Patent WO2009109665
TTTGCAC
>HC004564.1 Sequence 136 from Patent WO2009109665
TTAGGGC
>HC004563.1 Sequence 135 from Patent WO2009109665
GCACCTT
>HC004562.1 Sequence 134 from Patent WO2009109665
AGGGCAG
>HC004561.1 Sequence 133 from Patent WO2009109665
GCACCTT
>HC004560.1 Sequence 132 from Patent WO2009109665
CGATGGT
>HC004559.1 Sequence 131 from Patent WO2009109665
TGAATGT
>HC004558.1 Sequence 130 from Patent WO2009109665
TGAATGT
>HC004557.1 Sequence 129 from Patent WO2009109665
TCAGTGG
>HC004556.1 Sequence 128 from Patent WO2009109665
TCGATGG
>HC004555.1 Sequence 127 from Patent WO2009109665
TGAATGT
>HC004554.1 Sequence 126 from Patent WO2009109665
ACTGCAG
>HC004553.1 Sequence 125 from Patent WO2009109665
GCACTTT
>HC004552.1 Sequence 124 from Patent WO2009109665
AGCATTA
>HC004551.1 Sequence 123 from Patent WO2009109665
ACTTTAT
>HC004550.1 Sequence 122 from Patent WO2009109665
ACACTAC
>HC004549.1 Sequence 121 from Patent WO2009109665
GGAAGAT
>HC004548.1 Sequence 120 from Patent WO2009109665
CAGTGTT
>HC004547.1 Sequence 119 from Patent WO2009109665
CTCAGGG
>HC004546.1 Sequence 118 from Patent WO2009109665
ACACTCC
>HC004545.1 Sequence 117 from Patent WO2009109665
ACAGGGT
>HC004544.1 Sequence 116 from Patent WO2009109665
CAGTGCG
>HC004543.1 Sequence 115 from Patent WO2009109665
GCACTTT
>HC004542.1 Sequence 114 from Patent WO2009109665
CATTGCA
>HC004541.1 Sequence 113 from Patent WO2009109665
GCACTTT
>HC004540.1 Sequence 112 from Patent WO2009109665
ACATTCC
>DM371210.1 COMPOSITIONS AND METHODS RELATED TO CONTROLLED GENE EXPRESSION USING VIRAL VECTORS
TTTTTTA
>HB984120.1 Sequence 31 from Patent WO2009105335
TCCTAAA
>HB984116.1 Sequence 27 from Patent WO2009105335
CCCGGGG
>DM193578.1 PEPTIDE-DICER SUBSTRATE RNA CONJUGATES AS DELIVERY VEHICLES FOR SIRNA
GACAATG
>DM193566.1 PEPTIDE-DICER SUBSTRATE RNA CONJUGATES AS DELIVERY VEHICLES FOR SIRNA
GACAATG
>DM193554.1 PEPTIDE-DICER SUBSTRATE RNA CONJUGATES AS DELIVERY VEHICLES FOR SIRNA
GACAATG
>DM193222.1 Polynucleotide Amplifikation
ACACACG
>DM193221.1 Polynucleotide Amplifikation
ACACACT
>DM193220.1 Polynucleotide Amplifikation
ACACACC
>DM193219.1 Polynucleotide Amplifikation
ACACACA
>DM193218.1 Polynucleotide Amplifikation
ACACACN
>DM191491.1 Aurora Kinese A and Aurora Kinese B Gene Selective Expression Inhibitor
ACCACTT
>DM191244.1 hydrophobic substance addition nucleic acid having midkine inhibitory activity and use thereof
TTGGTGT
>DM203145.1 Multitargeting interfering RNAs and Methods of their Use and Design
CCTGGAG
>DM189835.1 NOVEL COSMETIC DESIGNS AND PRODUCTS USING INTRONIC RNA
TACTWAY
>DM203016.1 Multitargeting interfering RNAs and Methods of their Use and Design
TGCAGCT
>DM202881.1 Multitargeting interfering RNAs and Methods of their Use and Design
CCTGGAG
>DM202880.1 Multitargeting interfering RNAs and Methods of their Use and Design
CTCCAGG
>DM202813.1 Multitargeting interfering RNAs and Methods of their Use and Design
AGCTGCA
>DM202810.1 Multitargeting interfering RNAs and Methods of their Use and Design
CAAAACA
>DM202808.1 Multitargeting interfering RNAs and Methods of their Use and Design
TGTTTTG
>HB649991.1 Sequence 40 from Patent WO2009091659
GTAGAGT
>HB649957.1 Sequence 6 from Patent WO2009091659
TACTWAY
>HB649922.1 Sequence 21 from Patent WO2009094084
AAGAGAG
>HB854997.1 Sequence 54 from Patent WO2009095226
GGTTTGG
>DM179379.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
GGCCAGC
>DM179378.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
GGCTAGA
>DM179377.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
GGCTAGC
>DM179367.1 MULTICOMPONENT NUCLEIC ACID ENZYMES AND METHODS FOR THEIR USE
ACAACGA
>DM170577.1 HYPOXIA INDUCIBLE FACTOR-1 AND METHOD OF USE
RWACGTG
>DM170572.1 HYPOXIA INDUCIBLE FACTOR-1 AND METHOD OF USE
BACGTGC
>DM180318.1 RAPID PARALLEL NUCLEIC ACID ANALYSIS
AAAAAAA
>DM180315.1 RAPID PARALLEL NUCLEIC ACID ANALYSIS
CTCTCTG
>DM180313.1 RAPID PARALLEL NUCLEIC ACID ANALYSIS
GTCTCTC
>HB494344.1 Sequence 35 from Patent WO2009088837
GCATGCT
>DM165668.1 APTAMER-BASED COLORIMETRIC SENSOR SYSTEMS
TGGACCC
>DM165667.1 APTAMER-BASED COLORIMETRIC SENSOR SYSTEMS
ACCTGGG
>HB464051.1 Sequence 6 from Patent WO2009085215
CNACATC
>HB472001.1 Sequence 13 from Patent EP2083015
CATTCAN
>HB472000.1 Sequence 12 from Patent EP2083015
GGTGNAT
>HB471999.1 Sequence 11 from Patent EP2083015
GGTNAAT
>HB471998.1 Sequence 10 from Patent EP2083015
ATTCACC
>HB471997.1 Sequence 9 from Patent EP2083015
NGTGAAT
>HB471996.1 Sequence 8 from Patent EP2083015
NTGAATG
>HB471995.1 Sequence 7 from Patent EP2083015
NGAATGC
>DM148746.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CATCCCT
>DM148741.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CAACTGC
>DM148703.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CATCCCT
>DM148702.1 Compositions and Methods Relating to Orthogonal Ribosome mRNA Pairs
CAACTGC
>HB463353.1 Sequence 696 from Patent WO2008108989
NNAGAAW
>HA640123.1 Sequence 2 from Patent WO2009055076
NGGGGNN
>HA640122.1 Sequence 1 from Patent WO2009055076
NGGGGNN
>DM139888.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
CGGTGAA
>DM139883.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
GTGCGTC
>DM139855.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
GGGCGTA
>DM139845.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
CTGAGAC
>DM139829.1 NOVEL TARGETS FOR THE IDENTIFICATION OF ANTIBIOTICS THAT ARE NOT SUSCEPTIBLE TO ANTIBIOTIC RESISTANCE
CACATGC
>DM138917.1 Method for modulating responsiveness to steroids
GTTCGTC
>DM121219.1 Gene Analysis Method
CCGGGCC
>GM007058.1 Sequence 53 from Patent EP1921150
GGAGGGA
>HA641976.1 Sequence 6 from Patent WO2009058413
TACTWAY
>DM110382.1 GAMMARETROVIRUS ASSOCIATED WITH CANCER
TATAAAA
>DM110379.1 GAMMARETROVIRUS ASSOCIATED WITH CANCER
AGGTAAG
>DM102926.1 A polypeptide improving tolerance to iron deficiency of plant and use thereof
CAMGTTT
>GN368832.1 Sequence 28 from Patent WO2009049045
TCTTCGG
>GN367406.1 Sequence 127 from Patent WO2008068638
GNCGNTN
>GN367405.1 Sequence 126 from Patent WO2008068638
GNCGNTN
>GN367404.1 Sequence 125 from Patent WO2008068638
GNCGTTN
>GN346215.1 Sequence 979 from Patent WO2009043353
AGCATTA
>GN345273.1 Sequence 37 from Patent WO2009043353
CTAACTC
>GN345272.1 Sequence 36 from Patent WO2009043353
CTACCTC
>GN345266.1 Sequence 30 from Patent WO2009043353
CTACCTC
>GN345264.1 Sequence 28 from Patent WO2009043353
GTAGACT
>GN345259.1 Sequence 23 from Patent WO2009043353
ATGTAGC
>GN345244.1 Sequence 8 from Patent WO2009043353
ATAAGCT
>GN342355.1 Sequence 60 from Patent EP2053058
CGGAGTT
>GN342348.1 Sequence 53 from Patent EP2053058
CGGAGTT
>GN342326.1 Sequence 31 from Patent EP2053058
GATTTTT
>GN337994.1 Sequence 176 from Patent WO2009040113
GNGYGCN
>GN337993.1 Sequence 175 from Patent WO2009040113
NGYGCNT
>GN115361.1 Sequence 66 from Patent WO2009037183
GGGGGGG
>GN113930.1 Sequence 17 from Patent WO2009036228
RCCATGG
>GN113926.1 Sequence 13 from Patent WO2009036228
AACCTGG
>GN113925.1 Sequence 12 from Patent WO2009036228
AACTTGG
>GN113924.1 Sequence 11 from Patent WO2009036228
AACATGG
>GN113917.1 Sequence 4 from Patent WO2009036228
RNNATGG
>DM067975.1 Pgro expression units
GGAGGGA
>DM065728.1 A method of detecting a nucleic acid
TCTGTGC
>DM065727.1 A method of detecting a nucleic acid
TTGCCTT
>DM065724.1 A method of detecting a nucleic acid
GTTTGCC
>DM065723.1 A method of detecting a nucleic acid
GGGGCCT
>DM077464.1 ATTENUATED HUMAN PARAINFLUENZA VIRUS, METHODS AND USES THEREOF
AATTAGA
>DM077463.1 ATTENUATED HUMAN PARAINFLUENZA VIRUS, METHODS AND USES THEREOF
AATCAGA
>GN085233.1 Sequence 60 from Patent WO2009029293
CGGAGTT
>GN085226.1 Sequence 53 from Patent WO2009029293
CGGAGTT
>GN085204.1 Sequence 31 from Patent WO2009029293
GATTTTT
>GN087189.1 Sequence 7 from Patent EP1969144
TTTTTTA
>DM059424.1 METHOD OF GENOTYPING AND PHENOTYPING HEPATITIS B VIRUSES RESISTANT TO ANTIVIRAL MOLECULES
GCGCAGA
>DM059358.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TGTCGTT
>DM059357.1 IMMUNOSTIMULATORY OLIGONUCLEOTIDES
TGTCGTT
>DM049123.1 Mutant AOX1 promoters
TGGGGTC
>DM041722.1 PEF-TS expression units
AGGAGGA
>DM041702.1 P EF-TU Expression units
AGGAGGA
>DM041646.1 PSOD EXPRESSION UNITS
GAAAGGA
>DM041645.1 PSOD EXPRESSION UNITS
TATCATT
>DM049038.1 DEVICES AND METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCCGAC
>DM056951.1 Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
GATCTGT
>DM048494.1 APPARATUS AND SYSTEM HAVING DRY GENE SILENCING COMPOSITIONS
ATATGTG
>DM055633.1 Direct Reversal of the Suppressive Function of CD4+ Regulatory T Cells
GGGGGGG
>GN053761.1 Sequence 60 from Patent WO2008109465
CGGAGTT
>GN053754.1 Sequence 53 from Patent WO2008109465
CGGAGTT
>GN053732.1 Sequence 31 from Patent WO2008109465
GATTTTT
>GN053551.1 Sequence 8 from Patent WO2009021518
ACCCTAA
>GN053550.1 Sequence 7 from Patent WO2009021518
AACCCTA
>GN053549.1 Sequence 6 from Patent WO2009021518
CTAACCC
>GN053548.1 Sequence 5 from Patent WO2009021518
CCTAACC
>GN053547.1 Sequence 4 from Patent WO2009021518
TAACCCT
>GN053546.1 Sequence 3 from Patent WO2009021518
CCCTAAC
>DM036273.1 Multifunctional and multivalent angiogenesis inhibitors
CGATACA
>DM023422.1 COMPOSITIONS AND METHODS FOR INDUCING AN IMMUNE RESPONSE IN A MAMMAL AND METHODS OF AVOIDING AN IMMUNE RESPONSE TO OLIGONUCLEOTIDE AGENTS SUCH AS SHORT INTERFERING RNAs
GTCCTTC
>DM033160.1 Nucleic Acid Complex
ACCGACC
>DM033159.1 Nucleic Acid Complex
CCCCTTT
>DM032977.1 Polypeptide mutagenesis method
GAGTCAG
>DM032976.1 Polypeptide mutagenesis method
CTGACTC
>DM021835.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
AAAGGGG
>DM021834.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
TTTAAAG
>DM021833.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GGGAAAA
>DM021832.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
AAAAGGG
>DM021831.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GGGAAAG
>DM021830.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
AAAAAAC
>DM021829.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
AAAAAAA
>DM021828.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
AAAAAAG
>DM021827.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
TCCTGAT
>DM021826.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GCGAGTT
>DM021825.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
CTTAGGC
>DM021824.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GGATTTA
>DM021822.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
TTTAAAT
>DM021821.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
TTTAAAC
>DM021820.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GGGTTTT
>DM021819.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GGGTTTA
>DM021818.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GGGCCCC
>DM021817.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
GGGAAAC
>DM021816.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
AAATTTT
>DM021815.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
AAATTTA
>DM021814.1 Methods of screening biodiverse gene fragment libraries and uses of biological modulators isolated therefrom
AAAAAAC
>DM037994.1 METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE
NGGGGNN
>DM037993.1 METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE
NGGGGNN
>GN012517.1 Sequence 5 from Patent WO2009009399
ANNATGG
>DM001570.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
RTAAAYA
>DM001563.1 POPULATIONS OF REPORTER SEQUENCES AND METHODS OF THEIR USE
TGACTAA
>GM974827.1 Sequence 19 from Patent WO2008147899
CCGCCGC
>GM974826.1 Sequence 18 from Patent WO2008147899
CCGCCGC
>GM974822.1 Sequence 14 from Patent WO2008147899
CCGCCGC
>FB987285.1 Sequence 44 from Patent EP1918378
GAAAGGA
>FB987284.1 Sequence 43 from Patent EP1918378
TATCATT
>DL479450.1 YEAST-BASED THERAPEUTIC FOR CHRONIC HEPATITIS C INFECTION
ACCATGG
>DL465919.1 Glycine Riboswitches, Methods for Their Use, and Compositions for Use with Glycine Riboswitches
GACGCAA
>DL465916.1 Glycine Riboswitches, Methods for Their Use, and Compositions for Use with Glycine Riboswitches
GGAGGAA
>DL478372.1 USE OF RNA TRANS-SPLICING FOR ANTIBODY GENE TRANSFER AND ANTIBODY POLYPEPTIDE PRODUCTION
YNYTRAC
>DL477204.1 DELIVERY OF POLYNUCLEOTIDES
TTTCCGG
>DL477162.1 DELIVERY OF POLYNUCLEOTIDES
CCTTGAA
>DL477106.1 DELIVERY OF POLYNUCLEOTIDES
GATTTCC
>DL482928.1 TARGETED TRANS-SPLICING OF HIGHLY ABUNDANT TRANSCRIPTS FOR IN VIVO PRODUCTION OF RECOMBINANT PROTEINS
YNYTRAC
>DL469941.1 METHODS AND COMPOSITIONS FOR INHIBITION OF INNATE IMMUNE RESPONSES AND AUTOIMMUNITY
NGGGGNN
>DL469940.1 METHODS AND COMPOSITIONS FOR INHIBITION OF INNATE IMMUNE RESPONSES AND AUTOIMMUNITY
NGGGGNN
>GM835013.1 Sequence 55 from Patent WO2008120016
NGCNGCG
>GM834983.1 Sequence 25 from Patent WO2008120016
CGCNGCG
>GM834980.1 Sequence 22 from Patent WO2008120016
NGCNGCN
>GM697300.1 Sequence 5 from Patent WO2008085652
RTGTTGT
>GM619859.1 Sequence 21 from Patent EP1942198
AGGAGGA
>GM883776.1 Sequence 7 from Patent EP1995329
GGCCTTA
>GM883775.1 Sequence 6 from Patent EP1995329
AGGCTAG
>GM883774.1 Sequence 5 from Patent EP1995329
CGTACCG
>GM883773.1 Sequence 4 from Patent EP1995329
TAGTCGT
>GM883772.1 Sequence 3 from Patent EP1995329
GTCACTA
>GM883771.1 Sequence 2 from Patent EP1995329
TATTGTC
>GM883770.1 Sequence 1 from Patent EP1995329
AGGCTAT
>GM834981.1 Sequence 23 from Patent WO2008120016
NGCNGCG
>GM036965.1 Sequence 1 from Patent EP1925317
GAACAAG
>FB766838.1 Sequence 42 from Patent EP1908842
AGGAGGA
>FB765984.1 Sequence 83 from Patent EP1908841
AGGAGGA
>FB746169.1 Sequence 12 from Patent EP1903054
GAACAAG
>FB744608.1 Sequence 54 from Patent WO2008014979
GGTTTGG
>GM952248.1 Sequence 35 from Patent WO2008139262
GTTTTTG
>GM952215.1 Sequence 2 from Patent WO2008139262
TTTTTTT
>GM006700.1 Sequence 10 from Patent WO2008039538
NTTGTGT
>GM006691.1 Sequence 1 from Patent WO2008039538
NTTNTNT
>GM006692.1 Sequence 2 from Patent WO2008039538
GTTNTGT
>GM006693.1 Sequence 3 from Patent WO2008039538
NTTGTGT
>GM006694.1 Sequence 4 from Patent WO2008039538
GTTGTNT
>GM006695.1 Sequence 5 from Patent WO2008039538
NTTGTGT
>FB665105.1 Sequence 22 from Patent WO2007120120
AATTAGA
>FB665104.1 Sequence 21 from Patent WO2007120120
AATCAGA
>GM006696.1 Sequence 6 from Patent WO2008039538
NTTGTGT
>GM006637.1 Sequence 60 from Patent WO2008049078
CGGAGTT
>GM006630.1 Sequence 53 from Patent WO2008049078
CGGAGTT
>GM006608.1 Sequence 31 from Patent WO2008049078
GATTTTT
>GM614591.1 Sequence 3 from Patent EP1938833
GAACAAG
>FB706025.1 Sequence 5 from Patent WO2007125173
CCTTCGN
>FB702492.1 Sequence 36 from Patent WO2007107162
AACGGCC
>FB702490.1 Sequence 34 from Patent WO2007107162
AAGTTCT
>GM721420.1 Sequence 4 from Patent EP1967586
AACATGG
>GM709253.1 Sequence 60 from Patent WO2008089983
TGCTGCA
>GM709250.1 Sequence 57 from Patent WO2008089983
TACCCCT
>FB749218.1 Sequence 58 from Patent WO2008015447
CATGTCA
>FB751447.1 Sequence 55 from Patent EP1905829
CACNGAA
>FB750341.1 Sequence 1 from Patent EP1905844
GAACAAG
>DL233619.1 Nucleic acid for a cloning vector
CACCTGC
>DL204344.1 Mitochondrial Biology Expression Arrays
GCGGCCG
>DL230188.1 Novel full length cDNA
TATAAAA
>DL230181.1 Novel full length cDNA
AGGAAAA
>FB708120.1 Sequence 15 from Patent WO2007128524
GCTCTTC
>FB708111.1 Sequence 6 from Patent WO2007128524
GCTCTTC
>FB701042.1 Sequence 1 from Patent WO2006125977
GCGAAGC
>FB580694.1 Sequence 1 from Patent EP1852186
TGASTCA
>FB584084.1 Sequence 65 from Patent EP1867718
GGGTGGT
>FB584083.1 Sequence 64 from Patent EP1867718
TGGGTGG
>FB584082.1 Sequence 63 from Patent EP1867718
GGGTGGG
>FB584081.1 Sequence 62 from Patent EP1867718
GGGGTGG
>FB579987.1 Sequence 50 from Patent WO2006110589
TATAAAA
>FB579984.1 Sequence 47 from Patent WO2006110589
AGGTAAG
>DL192792.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
GCTCTTC
>DL192683.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
ATGGCCG
>DL192650.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
GATAAGA
>DL192455.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
CCAAACC
>DL192188.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
CTGGCAG
>DL192165.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
TGCGCAG
>DL201878.1 PEF-TS expression units
AGGAGGA
>DL192001.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
GCTCTTC
>DL191847.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
ATGGCCG
>DL191814.1 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS OF LUNG CANCER
GATAAGA
>DL193938.1 METHODS AND COMPOSITIONS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE RESPONSES
TCGTCGT
>DL193930.1 METHODS AND COMPOSITIONS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE RESPONSES
TTTTTCG
>DL196077.1 ADDITION OF TRANSGENES INTO ADENOVIRAL VECTORS
YNYTRAY
>DL196021.1 ASSEMBLY AND FOLDING OF Fc-INTERFERON-BETA FUSION PROTEINS
CCCGGGT
>DL193648.1 METHODS FOR MONITORING GENOMIC DNA OF ORGANISMS
AGCCGAC
>DL193488.1 Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression
TATTTAT
>FB513066.1 Sequence 79 from Patent WO2007112753
ACGAACA
>FB513063.1 Sequence 76 from Patent WO2007112753
TAGCATT
>FB513060.1 Sequence 73 from Patent WO2007112753
CACACTC
>FB513057.1 Sequence 70 from Patent WO2007112753
ATTTGCA
>CS697019.1 Sequence 38 from Patent WO2006089329
TGGGGTC
>CS259531.1 Sequence 10 from Patent WO2006000464
NANNYNN
>CS259530.1 Sequence 9 from Patent WO2006000464
NARNYNN
>CQ787917.1 Sequence 223 from Patent WO2004020664
AAAAACA
>CQ787910.1 Sequence 216 from Patent WO2004020664
TCTCTCT
>CQ787907.1 Sequence 213 from Patent WO2004020664
TCTCTCT
>CQ787906.1 Sequence 212 from Patent WO2004020664
TCTCTCT
>DL176498.1 GENETICALLY ENGINEERED VACCINE STRAIN
GTCACCC
>DL176330.1 GENETICALLY ENGINEERED VACCINE STRAIN
CTAATAG
>DL181624.1 IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES
TGTCGCT
>DL157572.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
TTCATTC
>DL157571.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
TCATTCA
>DL157570.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
CATTCAT
>DL157569.1 OLIGONUCLEOTIDE MEDIATED INHIBITION OF HEPATITIS B VIRUS AND HEPATITIS C VIRUS REPLICATION
ATTCATT
>DL181326.1 TRANSGENIC NON-HUMAN ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES
CACAGTG
>DL180140.1 Novel full length cDNA
TATAAAA
>DL180133.1 Novel full length cDNA
AGGAAAA
>CU971980.1 Brassica napus GSS, clone JBnB186P07, end read, primer SACR2(reverse), genomic survey sequence
GCCTCTT
>CU953954.1 Brassica napus GSS, clone JBnB118G21, end read, primer SACR2(reverse), genomic survey sequence
CGTTGAA
>CU967590.1 Brassica napus GSS, clone JBnB039K19, end read, primer SACR2(reverse), genomic survey sequence
CCTTGTA
>CU970167.1 Brassica napus GSS, clone JBnB005E23, end read, primer SACR2(reverse), genomic survey sequence
CCATCTG
>CU930754.1 Brassica napus GSS, clone JBnB039B09, end read, primer SACR2(reverse), genomic survey sequence
CCTTTAA
>FB300268.1 Sequence 34 from Patent WO2007114986
CTCGGGG
>FB300267.1 Sequence 33 from Patent WO2007114986
CCCCGAG
>FB300246.1 Sequence 12 from Patent WO2007114986
CCGCCAC
>FB300245.1 Sequence 11 from Patent WO2007114986
GTGGCGG
>DL129357.1 Virus causing respiratory tract illness in susceptible mammals
TAAAAAH
>DL080522.1 IL-7 Fusion Proteins
CTTAAGC
>DL080515.1 IL-7 Fusion Proteins
CCCGGGT
>DL076006.1 A METHOD FOR THE TREATMENT OF MALIGNANT DISEASES BY INHIBITING NUCLEOLIN
GCATGCT
>DL073959.1 HBsAg particle with low antigenicity and method for producing same
CAGACTC
>DL073957.1 HBsAg particle with low antigenicity and method for producing same
AGGAGTC
>DL081491.1 METHOD FOR NUCLEIC ACID ANALYSIS
CTCTCTG
>DL081489.1 METHOD FOR NUCLEIC ACID ANALYSIS
GTCTCTC
>DL071551.1 Synthetic nucleic acid molecule compositions and methods of preparation
TGASTMA
>DL070583.1 COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
TGCAATC
>DL070551.1 COMPOUNDS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
TGCAATC
>DL007574.1 Pgro expression units
GGAGGGA
>DJ493808.1 Process for producing amino acids
CAGGACG
>DJ493807.1 Process for producing amino acids
CAGGAAG
>DJ493806.1 Process for producing amino acids
CAGGATG
>DJ436654.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BY SMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTCTGT
>DJ440565.1 Modified Polynucleotides For Reducing Off-Target Effects In RNA Interference
ATATGTG
>DJ428160.1 Method of partial waxy wheat analysis
GATCATG
>DJ402036.1 METHOD FOR DIAGNOSING COLORECTAL CANCERS
CTTTGAT
>DJ399097.1 substances inhibitory to AP-1 motif-mediated gene expression
TGASTCA
>DJ418929.1 APTAMERS SELECTED FROM LIVE TUMOR CELLS AND THE USE THEREOF
CTTTTTT
>DJ418925.1 APTAMERS SELECTED FROM LIVE TUMOR CELLS AND THE USE THEREOF
GCGGTAT
>DJ381362.1 Renilla Reniformis Green Fluorescent Protein and Mutants Thereof
ACCATGG
>DJ388857.1 Novel Dual Oxidases as Mitogenic and Endocrine Regulators
GGCATGC
>CS723910.1 Sequence 168 from Patent WO2007100584
GGGACTT
>DJ357255.1 Transgenic plants
AGGAGGT
>DJ327194.1 Oligonucleotide immobilizing solid phase carrier
ATGGGCC
>DI010978.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNACG
>DI008350.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNACC
>DI021157.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
GTGGAAG
>DI023464.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNGCC
>DJ090013.1 EXPRESSION OF APOA-1 AND VARIANTS THEREOF USING SPLICEOSOME MEDIATED RNA TRANS-SPLICING
YNYTRAC
>DJ090003.1 NUCLEIC ACID SEQUENCING BY RAMAN MONITORING OF UPTAKE OF NUCLEOTIDES DURING MOLECULAR REPLICATION
AGACATA
>DI166393.1 YEAST-BASED THERAPEUTIC FOR CHRONIC HEPATITIS C INFECTION
ACCATGG
>DI158764.1 Psod-Expressionseinheiten
TATCATT
>DI157438.1 Pgro-Expressionseinheiten
GGAGGGA
>DI156747.1 Psod-Expressionseinheiten
GAAAGGA
>DI155918.1 NUCLEIC ACID SEQUENCING BY RAMAN MONITORING OF UPTAKEOF NUCLEOTIDES DURING MOLECULAR REPLICATION
AGACATA
>DI151375.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES BYSMALL OLIGONUCLEOTIDE-BASED COMPOUNDS
TCTCTGT
>DI138528.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
TTTTTTT
>DI137757.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
AAAAAAA
>DI136882.1 CPG FORMULATIONS AND RELATED METHODS
GGGNGGG
>DI132205.1 Method for robust genotyping using DNA chip having adiscriminating probe and amplicon probe immobilized thereon andDNA chip used therein
GCCCCCT
>DI125055.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
GTCGTTC
>DI124820.1 CPG FORMULATIONS AND RELATED METHODS
TGTCGYT
>DI120120.1 METHOD FOR INHIBITING IRES-DEPENDENT TRANSLATION BY USING ANOLIGO DNA
CCCCCTT
>DI109277.1 IL-7 Fusion Proteins
CTTAAGC
>DI104981.1 Caudal protein recognizing E2F promoter, transformants foroverexpressing caudal, and use thereof
TATAAAG
>DI099523.1 Method to Inhibit Cell Growth Using Oligonucleotides
AGTATGA
>DI093064.1 METHODS AND COMPOSITIONS FOR LINEAR ISOTHERMAL AMPLIFICATION OFPOLYNUCLEOTIDE SEQUENCES
GGAATTC
>DI091690.1 DNA sequences comprising gene transcription regulatory qualities and
CAGNGGG
>DI088821.1 Compounds and methods for treatment and diagnosis of Chlamydial infection
TGCAATC
>DI086551.1 Immunostimulatory Nucleic Acids
TCAACGT
>DI085857.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNAGG
>DI083528.1 DNA sequences comprising gene transcription regulatory qualities and
AGCNCCC
>DI083508.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
CTGGATG
>DI083156.1 DNA sequences comprising gene transcription regulatory qualities and
GGCNCCC
>DI081667.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
CAGGAAG
>DI081139.1 DNA sequences comprising gene transcription regulatory qualities and
CTGNCCC
>DI076061.1 DNA sequences comprising gene transcription regulatory qualities and
GGANCCC
>DI074522.1 Compounds and methods for treatment and diagnosis of Chlamydial infection
TGCAATC
>DI070416.1 DNA sequences comprising gene transcription regulatory qualities and
GAGNCCC
>DI067380.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNCGC
>DI067083.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
CTAATAG
>DI065809.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNACC
>DI064406.1 DNA sequences comprising gene transcription regulatory qualities and
GCANCGC
>DI062804.1 DNA sequences comprising gene transcription regulatory qualities and
AGGNCGC
>DI062029.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
CTGGAAG
>DI061881.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
GAGGATG
>DI056265.1 DNA sequences comprising gene transcription regulatory qualities and
AGGNCCC
>DI055073.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNCCC
>DI052148.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNCGG
>DI050581.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNCCG
>DI049985.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNTGC
>DI047942.1 Compounds and methods for treatment and diagnosis of Chlamydial infection
TGCAATC
>DI046104.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
GCGGAAG
>DI044625.1 Immunostimulatory Nucleic Acids
CAACGTT
>DI043591.1 NOVEL MINIATURE INVERTED-REPEAT TRANSPOSABLE ELEMENTS (MITEs)-LIKEELEMENT AND TRANSCRIPTIONAL ACTIVATION ELEMENT
AATGCAA
>DI042626.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
GTGGATG
>DI041005.1 DNA sequences comprising gene transcription regulatory qualities and
AGANGGC
>DI039926.1 NOVEL MINIATURE INVERTED-REPEAT TRANSPOSABLE ELEMENTS (MITEs)-LIKEELEMENT AND TRANSCRIPTIONAL ACTIVATION ELEMENT
TATGCAA
>DI037177.1 RECOMBINANT VIRUS VECTORS ENCODING HUMAN PAPILLOMAVIRUS PROTEINS
TTTTTCT
>DI035815.1 Antisense Inhibition of ras Gene with Chimeric and Alternating Oligonucleotides
CCGACGG
>DI034075.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNGGC
>DI029009.1 Antisense Oligonucleotide Inhibition of ras
CCGACGG
>DI025930.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNGCC
>DI025379.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNCCC
>DI025025.1 DNA sequences comprising gene transcription regulatory qualities and
CAGNGCC
>DI023978.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNGAC
>DI023901.1 DNA sequences comprising gene transcription regulatory qualities and
AGCNGCC
>DI023815.1 RECOMBINANT VIRUS VECTORS ENCODING HUMAN PAPILLOMAVIRUS PROTEINS
TTTTTAT
>DI018780.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNGCC
>DI018439.1 CHORIONIC GONADOTROPIN DNA VACCINES AND METHODS
ACCACCC
>DI017164.1 DNA sequences comprising gene transcription regulatory qualities and
CCANCGG
>DI014670.1 Immunostimulatory Nucleic Acids
AACGTTG
>DI007306.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
CAGGAAG
>DI003768.1 Nanostructures Containing PNA Joining and Functional Elements
GGGGGGG
>DI003727.1 Nanostructures Containing PNA Joining and Functional Elements
AGAGAGA
>DI005884.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNCCC
>DI005766.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNGGA
>DI002973.1 Nanostructures Containing PNA Joining and Functional Elements
GAAGGAG
>DI002946.1 Nanostructures Containing PNA Joining and Functional Elements
GGGAAAA
>DI033479.1 DNA sequences comprising gene transcription regulatory qualities and
AGCNGCG
>DJ082249.1 Anti-CD14 Antibody Fusion Protein
GSGGGGS
>DI011645.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNGAG
>DI162229.1 PEF-TS expression units
AGGAGGA
>DI153556.1 P EF-TU-Expressionseinheiten
AGGAGGA
>DI144090.1 GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTALCARCINOMA
CTTTGGC
>DI139647.1 CPG FORMULATIONS AND RELATED METHODS
CAACGTT
>DI138173.1 Compounds and methods for treatment and diagnosis ofChlamydial infection
TGCAATC
>DI133442.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
AGGTAAG
>DI128070.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OFOLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIEDIMMUNOSTIMULATORY DINUCLEOTIDES
TCGTTCT
>DI126042.1 Compounds and methods for treatment and diagnosis ofChlamydial infection
TGCAATC
>DI119119.1 Statistical Analysis Of RegulatoryFactor Binding Sites Of Differentially Expressed Genes
TGACTCA
>DI109825.1 IL-7 Fusion Proteins
CCCGGGT
>DI099476.1 Method to Inhibit Cell Growth Using Oligonucleotides
AGTATGA
>DI091093.1 Surface Transfection and Expression Procedure
TGACTCA
>DI087883.1 ALVAC CANARYPOX VIRUS RECOMBINANTS AND USES THEREOF
GTCACCC
>DI086317.1 DNA sequences comprising gene transcription regulatory qualities and
CGCNGGC
>DI079425.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
GAGGAAG
>DI077512.1 RECOMBINANT VIRUS VECTORS ENCODING HUMAN PAPILLOMAVIRUS PROTEINS
TTTTTNT
>DI074924.1 DNA sequences comprising gene transcription regulatory qualities and
GCCNCGC
>DI071116.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNTGC
>DI067744.1 Genomic DNA and Promoter of lipoxygenase gene and theirapplication
TAACAAT
>DI066674.1 DNA sequences comprising gene transcription regulatory qualities and
CCANCCC
>DI061593.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
CAGGATG
>DI061299.1 Nucleotide Sequences for Gene Regulation and Methods ofUse Thereof
GAGGAAA
>DI059496.1 DNA sequences comprising gene transcription regulatory qualities and
CGGNGCA
>DI059398.1 Therapeutically Useful Synthetic Oligonucleotides
GGGTGGG
>DI058698.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNCGG
>DI054660.1 Therapeutically Useful Synthetic Oligonucleotides
GGGGTGG
>DI049846.1 Therapeutically Useful Synthetic Oligonucleotides
TGGGTGG
>DI049556.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
CTAATAG
>DI036645.1 DNA sequences comprising gene transcription regulatory qualities and
GCGNCCA
>DI030352.1 Compounds and methods for treatment and diagnosis of Chlamydial infection
TGCAATC
>DI024898.1 DNA sequences comprising gene transcription regulatory qualities and
CCCNGCG
>DI024838.1 TROVAC FOWLPOX VIRUS RECOMBINANTS AND USES THEREOF
GTCACCC
>DI024582.1 DNA sequences comprising gene transcription regulatory qualities and
ACGNCCC
>DI023772.1 Genomic DNA and Promoter of lipoxygenase gene and theirapplication
TATAAAT
>DI015105.1 DNA sequences comprising gene transcription regulatory qualities and
CCGNCAG
>DI010151.1 Therapeutically Useful Synthetic Oligonucleotides
GGGTGGT
>DJ066874.1 PSOD EXPRESSION UNITS
GAAAGGA
>DJ066873.1 PSOD EXPRESSION UNITS
TATCATT
>DJ066832.1 P EF-TU Expression units
AGGAGGA
>DJ068811.1 Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells
GGTCACC
>DJ063272.1 Method, apparatus, and computer program for searching miRNA, and recording medium
ATCCTGC
>DJ062051.1 Statistical Analysis Of Regulatory Factor Binding Sites Of Differentially Expressed Genes
TGACTCA
>DJ058393.1 NF-kB Oligonucleotide Decoy Molecules
CCTTGAA
>DJ058337.1 NF-kB Oligonucleotide Decoy Molecules
GATTTCC
>DJ055335.1 Versatile tRNA acylation catalytic RNAs and uses thereof
CCGCATC
>DJ055333.1 Versatile tRNA acylation catalytic RNAs and uses thereof
CCGCGGC
>DJ054819.1 DICATIONIC COMPOUNDS WHICH SELECTIVELY RECOGNIZE G-QUADRUPLEX DNA
TTAGGGT
>CS813025.1 Sequence 49 from Patent WO2007106118
TGGACCC
>CS813024.1 Sequence 48 from Patent WO2007106118
ACCTGGG
>DJ020620.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
GGGGGGG
>DJ020619.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
CCCCCCC
>DJ020599.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
TTTTTTT
>DJ020597.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
AAAAAAA
>DJ020592.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
GCGCGCG
>DJ020591.1 Double-Stranded RNA Structures and Constructs, and Methods For Generating and Using the Same
CGCGCGC
>FB295824.1 Sequence 16 from Patent EP1849873
CTGATCA
>FB294363.1 Sequence 7 from Patent EP1847614
GGGGGGG
>FB294362.1 Sequence 6 from Patent EP1847614
TATTTAA
>DJ045956.1 DNA Detection Method,and DNA Detection Apparatus
ACGCGAT
>DJ045955.1 DNA Detection Method,and DNA Detection Apparatus
ATCACGT
>DJ045954.1 DNA Detection Method,and DNA Detection Apparatus
ATCGCGT
>DJ045953.1 DNA Detection Method,and DNA Detection Apparatus
ACGCGAT
>DJ045952.1 DNA Detection Method,and DNA Detection Apparatus
ATCGCGT
>CS706573.1 Sequence 24 from Patent WO2006091915
TGTCGTT
>CS706572.1 Sequence 23 from Patent WO2006091915
TGTCGTT
>CS714633.1 Sequence 12 from Patent EP1832603
GAACAAG
>CS792275.1 Sequence 16 from Patent EP1830190
GGTCACC
>DJ041969.1 Chemiluminescent Compounds
GACCGGT
>CS688544.1 Sequence 5 from Patent WO2007062445
ACACACG
>CS688543.1 Sequence 4 from Patent WO2007062445
ACACACT
>CS688542.1 Sequence 3 from Patent WO2007062445
ACACACC
>CS688541.1 Sequence 2 from Patent WO2007062445
ACACACA
>CS688540.1 Sequence 1 from Patent WO2007062445
ACACACN
>DJ003667.1 CTGF gene expression repressing agent
GAGTGTG
>CS669060.1 Sequence 2 from Patent WO2006066003
NGGGGNN
>CS669059.1 Sequence 1 from Patent WO2006066003
NGGGGNN
>CS673240.1 Sequence 5 from Patent WO2007059715
CATGGCA
>CS672910.1 Sequence 34 from Patent WO2007062107
GTAGTAG
>CS672909.1 Sequence 33 from Patent WO2007062107
TATATAT
>CS672908.1 Sequence 32 from Patent WO2007062107
TCTCTCT
>CS672907.1 Sequence 31 from Patent WO2007062107
TGTGTGT
>CS672906.1 Sequence 30 from Patent WO2007062107
TTATTAT
>CS672905.1 Sequence 29 from Patent WO2007062107
TTGTTGT
>DD464065.1 SELF-ADDRESSABLE SELF-ASSEMBLING MICROELECTRONIC SYSTEMS AND DEVICES FOR MOLECULAR BIOLOGICAL ANALYSIS AND DIAGNOSTICS
ACAACGC
>DD464064.1 SELF-ADDRESSABLE SELF-ASSEMBLING MICROELECTRONIC SYSTEMS AND DEVICES FOR MOLECULAR BIOLOGICAL ANALYSIS AND DIAGNOSTICS
ACACCGC
>DD463951.1 Method for Sowing CONTIG Map
ACGCGAG
>DD463947.1 Method for Sowing CONTIG Map
ACGCGAG
>DD453615.1 Anti-CD14 Antibody Fusion Protein
GSGGGGS
>DD452824.1 84P2A9:A PROSTATE AND TESTIS SPECIFIC PROTEIN HIGHLY EXPRESSED IN PROSTATE CANCER
AACATGG
>CS641550.1 Sequence 29 from Patent EP1806357
RWACGTG
>CS641545.1 Sequence 24 from Patent EP1806357
BACGTGC
>CS641473.1 Sequence 126 from Patent WO2007056153
GACAATG
>CS641461.1 Sequence 114 from Patent WO2007056153
GACAATG
>CS641449.1 Sequence 102 from Patent WO2007056153
GACAATG
>CS628261.1 Sequence 61 from Patent WO2006053571
ATTCCCG
>DD450557.1 METHODS FOR MODULATING ANGIOGENESIS WITH APELIN COMPOSITIONS
BACGTGK
>CS619842.1 Sequence 12 from Patent EP1800697
GAACAAG
>CS618811.1 Sequence 185 from Patent WO2007049062
GATTCCG
>CS607100.1 Sequence 336 from Patent WO2007039903
CCTCCTC
>CS607087.1 Sequence 323 from Patent WO2007039903
GGCAGAC
>CS591080.1 Sequence 12 from Patent EP1792613
TTAGGGT
>CS565831.1 Sequence 2 from Patent WO2006028742
NGGGGNN
>CS565830.1 Sequence 1 from Patent WO2006028742
NGGGGNN
>CS570673.1 Sequence 2 from Patent WO2006042232
YNYTRAC
>CS558709.1 Sequence 3 from Patent WO2005022161
GACCGGT
>DD432048.1 MODIFIED TERT PROMOTER WITH ENHANCED TUMOR-SPECIFICITY AND STRENGTH AND RECOMBINANT VECTOR COMPRISING THE SAME
GGGGCGG
>CS502971.1 Sequence 93 from Patent WO2007010221
CATCCCT
>CS502966.1 Sequence 88 from Patent WO2007010221
CAACTGC
>CS502928.1 Sequence 50 from Patent WO2007010221
CATCCCT
>CS502927.1 Sequence 49 from Patent WO2007010221
CAACTGC
>CS500250.1 Sequence 3 from Patent WO2006107317
AGCCGAC
>DD414226.1 PROSTATE CANCER-RELATED COMPOSITIONS, METHODS, AND KITS BASED ON DNA MACROARRAY PROTEOMICS PLATFORMS
CACAATG
>DD414144.1 Random Array DNA Analysis by Hybridization
ATGGTNN
>DD414143.1 Random Array DNA Analysis by Hybridization
ATCGTNN
>DD414140.1 Random Array DNA Analysis by Hybridization
ATCGGNN
>DD414139.1 Random Array DNA Analysis by Hybridization
ATAGGNN
>DD414136.1 Random Array DNA Analysis by Hybridization
CCAGGNN
>DD414135.1 Random Array DNA Analysis by Hybridization
CCTGGNN
>DD414132.1 Random Array DNA Analysis by Hybridization
CGATGNN
>DD414131.1 Random Array DNA Analysis by Hybridization
CGTTGNN
>DD417460.1 Method of diagnosing and treating inflammatory diseases using PAC-1 (DUSP2)
CCACACC
>DD393690.1 Enzymatic encoding
GCAGCCA
>DD393689.1 Enzymatic encoding
TCGAGCG
>CS459433.1 Sequence 88 from Patent EP1733735
TGTCGYT
>CS459370.1 Sequence 25 from Patent EP1733735
CAACGTT
>DD367940.1 Pharmaceutical Agent Comprising Decoy and Its Use For Bone Metabolism
AACCACA
>DD367931.1 Pharmaceutical Agent Comprising Decoy and Its Use For Bone Metabolism
TGAGTCA
>DD367930.1 Pharmaceutical Agent Comprising Decoy and Its Use For Bone Metabolism
TGASTMA
>DD362939.1 DNA Conjugate and,method for determining DNA
TACCAGC
>DD362935.1 DNA Conjugate and,method for determining DNA
ATCACGT
>DD362934.1 DNA Conjugate and,method for determining DNA
ATCGCGT
>DD362933.1 DNA Conjugate and,method for determining DNA
ACGCGAT
>DD360700.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCGTTCT
>DD360692.1 MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GTCGTTC
>DD358019.1 Administration of Transposon-Based Vectors to Reproductive Organs
ACCATGT
>DD357987.1 Administration of Transposon-Based Vectors to Reproductive Organs
ACCATGA
>DD357986.1 Administration of Transposon-Based Vectors to Reproductive Organs
GACATGA
>DD357985.1 Administration of Transposon-Based Vectors to Reproductive Organs
AAGATGG
>DD357984.1 Administration of Transposon-Based Vectors to Reproductive Organs
ACGATGA
>DD357983.1 Administration of Transposon-Based Vectors to Reproductive Organs
AAGATGT
>DD357982.1 Administration of Transposon-Based Vectors to Reproductive Organs
ACCATGT
>DD357981.1 Administration of Transposon-Based Vectors to Reproductive Organs
ACCATGG
>DD357949.1 Production of Multimeric Proteins
ACCATGT
>DD357948.1 Production of Multimeric Proteins
ACCATGA
>DD357947.1 Production of Multimeric Proteins
GACATGA
>DD357946.1 Production of Multimeric Proteins
AAGATGG
>DD357945.1 Production of Multimeric Proteins
ACGATGA
>DD357944.1 Production of Multimeric Proteins
AAGATGT
>DD357943.1 Production of Multimeric Proteins
ACCATGT
>DD357942.1 Production of Multimeric Proteins
ACCATGG
>CS448667.1 Sequence 141 from Patent WO2006111541
ACGTGGC
>CS448636.1 Sequence 110 from Patent WO2006111541
AATGATT
>CS448635.1 Sequence 109 from Patent WO2006111541
AATCATT
>CS448634.1 Sequence 108 from Patent WO2006111541
AATTATT
>CS448633.1 Sequence 107 from Patent WO2006111541
AATAATT
>CS435975.1 Sequence 119 from Patent WO2006085973
AATCGGA
>CS435969.1 Sequence 113 from Patent WO2006085973
TCGATAG
>CS435939.1 Sequence 83 from Patent WO2006085973
TCGTCGC
>CS435915.1 Sequence 59 from Patent WO2006085973
ACGTTGA
>DD335989.1 DETECTION OF CHEMICAL LIGATION USING FLUORESCENCE QUENCHING LEAVING GROUPS
CCGTCGG
>DD334901.1 Chimera (double) decoy
TGAGTCA
>DD334893.1 Chimera (double) decoy
TGASTMA
>DD347647.1 Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor
CCACACC
>DD345277.1 Oligonucleotide Conjugates
GGGTTAG
>DD352007.1 ISOLATION OF ANTISENSE OLIGONUCLEOTIDES
TCCGTCA
>DD352006.1 ISOLATION OF ANTISENSE OLIGONUCLEOTIDES
TCCGTCA
>DD347711.1 Methods for Identifying Functionally Related Genes and Drug Targets
TTTATTT
>CS413748.1 Sequence 634 from Patent EP1700603
AACGTTG
>CS413747.1 Sequence 633 from Patent EP1700603
TCAACGT
>CS413727.1 Sequence 613 from Patent EP1700603
CAACGTT
>CS410835.1 Sequence 33 from Patent WO2006043271
CTGTCAG
>CS410616.1 Sequence 60 from Patent WO2006029196
AGTGTGG
>DD323127.1 nucleotide analogues
TCGCGCG
>DD323126.1 nucleotide analogues
ACGCGCG
>DD323125.1 nucleotide analogues
TCGCGCG
>DD323124.1 nucleotide analogues
ACGCGCG
>DD329680.1 Methods and Compositions for use in Spliceosome Mediated RNA Trans-splicing
YNYTRAC
>DD322103.1 A Transcript Mapping Method
AAAAAAA
>DD321889.1 TEMPLATE-DEPENDENT LIGATION WITH PNA-DNA CHIMERIC PROBES
TAGTTCT
>DD328330.1 Methods for Diagnosing the Presence or Stage of Cancer
CCGATGG
>DD325460.1 GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA
CTTTGGC
>CS388995.1 Sequence 24 from Patent EP1696040
GCGCAGA
>CS399055.1 Sequence 3 from Patent WO2006089192
AGCCGAC
>CS409765.1 Sequence 24 from Patent WO2006090262
GCGCAGA
>CS409709.1 Sequence 95 from Patent WO2006089950
ACGTGGC
>CS403233.1 Sequence 6 from Patent WO2006084754
GATCTGT
>DD290363.1 TGF-beta gene expression repression agent
ACTCTCC
>A29136.1 oligo DNA fragment from patent GB2241703
CTTAGAG
>CS377426.1 Sequence 117 from Patent EP1688147
TGTCGYT
>CS377364.1 Sequence 55 from Patent EP1688147
CAACGTT
>CS363917.1 Sequence 12 from Patent WO2006077411
GAGTCAG
>CS363916.1 Sequence 11 from Patent WO2006077411
CTGACTC
>CS361029.1 Sequence 232 from Patent WO2006076288
CAGAAGG
>CS361008.1 Sequence 211 from Patent WO2006076288
CAGGACC
>CS360999.1 Sequence 202 from Patent WO2006076288
CATTGGA
>CS360945.1 Sequence 148 from Patent WO2006076288
CATTGGA
>BD268076.1 Cell specific promoters of uncoupling protein 3
TATAAGA
>BD267918.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
TGTCGCT
>BD267915.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
TGTCGTT
>BD267852.1 Methods for the prevention and treatment of parasitic infections and related diseases using CPG oligonucleotides
CAACGTT
>BD265780.1 Method of acquiring full-length nucleic acid sequence using Escherichia coli topoisomerase III and its homolog
GCAACTT
>BD264568.1 Compounds and methods for treatment and diagnosis of chlamydial infection
TGCAATC
>BD264536.1 Compounds and methods for treatment and diagnosis of chlamydial infection
TGCAATC
>BD261309.1 Methods and products for inducing mucosal immunity
TGTCGYT
>BD261246.1 Methods and products for inducing mucosal immunity
CAACGTT
>BD261154.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
TGTCGYT
>BD261083.1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
CAACGTT
>BD251957.1 Artificial matrix attachment region for increasing expression of genes introduced in plant cells
AAAAAAA
>BD244966.1 Targeted gene modification by parvoviral vectors
CGGACCG
>BD244956.1 Targeted gene modification by parvoviral vectors
CGGACCG
>BD244077.1 Determination method of nucleotide sequence using arbitrary primer and low stringency
AGGCACT
>BD236921.1 Chorionic gonadotropin DNA vaccine and method
ACCACCC
>BD211370.1 Method of finding restriction enzyme
RYYYAAC
>BD211369.1 Method of finding restriction enzyme
GTTRRRY
>BD205612.1 Method of controlling hematopoiesis by using CpG oligonucleotide
TGTCGYT
>BD205541.1 Method of controlling hematopoiesis by using CpG oligonucleotide
CAACGTT
>CS355417.1 Sequence 83 from Patent WO2006069711
AGGAGGA
>AX355466.1 Sequence 494 from Patent WO0197843
TCAACGT
>AX355107.1 Sequence 135 from Patent WO0197843
CAACGTT
>AX354992.1 Sequence 20 from Patent WO0197843
AACGTTG
>A29904.1 Artificial DNA for tet-gen like -10 region of promoter
TAACCTT
>CS279001.1 Sequence 1 from Patent EP1637607
TTTGACC
>CS276878.1 Sequence 43 from Patent WO2005116213
TAACGAA
>CS266283.1 Sequence 14 from Patent WO2005121178
CCTNAGG
>CS246203.1 Sequence 142 from Patent WO2005119262
TTGCTAT
>CS244868.1 Sequence 8 from Patent WO2005118617
ATTGCAT
>CS238776.1 Sequence 232 from Patent WO2005116070
CAGAAGG
>CS238755.1 Sequence 211 from Patent WO2005116070
CAGGACC
>CS238746.1 Sequence 202 from Patent WO2005116070
CATTGGA
>CS238692.1 Sequence 148 from Patent WO2005116070
CATTGGA
>CS235681.1 Sequence 12 from Patent EP1604688
GAACAAG
>CS226172.1 Sequence 42 from Patent WO2005059093
AGGAGGA
>CS209901.1 Sequence 1064 from Patent EP1600510
CAGNGCC
>CS209900.1 Sequence 1063 from Patent EP1600510
CCCNACG
>CS209881.1 Sequence 1044 from Patent EP1600510
AGANGGC
>CS209875.1 Sequence 1038 from Patent EP1600510
CCCNGAG
>CS209841.1 Sequence 1004 from Patent EP1600510
CCGNTGC
>CS209810.1 Sequence 973 from Patent EP1600510
ACGNCCC
>CS209806.1 Sequence 969 from Patent EP1600510
GAGNCCC
>CS209781.1 Sequence 944 from Patent EP1600510
CCGNCCC
>CS209768.1 Sequence 931 from Patent EP1600510
CCGNAGG
>CS209754.1 Sequence 917 from Patent EP1600510
AGGNCCC
>CS209740.1 Sequence 903 from Patent EP1600510
CCANCCC
>CS209739.1 Sequence 902 from Patent EP1600510
CGCNGGA
>CS209728.1 Sequence 891 from Patent EP1600510
GCGNCCA
>CS209693.1 Sequence 856 from Patent EP1600510
CCCNGCC
>CS209644.1 Sequence 807 from Patent EP1600510
CCCNCGG
>CS209628.1 Sequence 791 from Patent EP1600510
CGGNTGC
>CS209563.1 Sequence 726 from Patent EP1600510
AGCNGCC
>CS209534.1 Sequence 697 from Patent EP1600510
GGCNCCC
>CS209491.1 Sequence 654 from Patent EP1600510
AGCNCCC
>CS209478.1 Sequence 641 from Patent EP1600510
CCCNCGC
>CS209432.1 Sequence 595 from Patent EP1600510
GCANCGC
>CS209413.1 Sequence 576 from Patent EP1600510
CCCNACC
>CS209412.1 Sequence 575 from Patent EP1600510
CCGNCGG
>CS209406.1 Sequence 569 from Patent EP1600510
CGCNGCC
>CS209397.1 Sequence 560 from Patent EP1600510
CTGNCCC
>CS209391.1 Sequence 554 from Patent EP1600510
AGGNCGC
>CS209389.1 Sequence 552 from Patent EP1600510
CGGNGGC
>CS209363.1 Sequence 526 from Patent EP1600510
GCGNACC
>CS209356.1 Sequence 519 from Patent EP1600510
CGGNCCC
>CS209347.1 Sequence 510 from Patent EP1600510
GCCNCGC
>CS209319.1 Sequence 482 from Patent EP1600510
AGCNGCG
>CS209309.1 Sequence 472 from Patent EP1600510
CCCNCCG
>CS209306.1 Sequence 469 from Patent EP1600510
CGCNGGC
>CS209298.1 Sequence 461 from Patent EP1600510
CCANCGG
>CS209293.1 Sequence 456 from Patent EP1600510
CCGNCAG
>CS209278.1 Sequence 441 from Patent EP1600510
CAGNGGG
>CS209264.1 Sequence 427 from Patent EP1600510
CGGNGCA
>CS209246.1 Sequence 409 from Patent EP1600510
GGANCCC
>CS209236.1 Sequence 399 from Patent EP1600510
CGGNGCC
>CS209212.1 Sequence 375 from Patent EP1600510
CCCNCCC
>CS209209.1 Sequence 372 from Patent EP1600510
CGCNGAC
>CS209193.1 Sequence 356 from Patent EP1600510
CCCNGCG
>CS207479.1 Sequence 187 from Patent WO2005109000
TTGCTAT
>CS206728.1 Sequence 29 from Patent WO2005109001
TTGCTAT
>CS184093.1 Sequence 21 from Patent WO2005097992
ATATGTG
>CS177429.1 Sequence 30 from Patent WO2005093097
CTTTTTT
>CS177425.1 Sequence 26 from Patent WO2005093097
GCGGTAT
>CS174895.1 Sequence 16 from Patent WO2005090595
GCCCGCC
>CS166401.1 Sequence 2 from Patent WO2005066369
AGACATA
>CS165382.1 Sequence 18 from Patent WO2005085454
AGGAGGT
>CS141778.1 Sequence 23 from Patent WO2005068638
CTACTTC
>CS140621.1 Sequence 76 from Patent WO2005071096
TTTATAC
>CS140620.1 Sequence 75 from Patent WO2005071096
TTGATAC
>CS140619.1 Sequence 74 from Patent WO2005071096
TTCATAC
>CS140618.1 Sequence 73 from Patent WO2005071096
TTAATAC
>CS140617.1 Sequence 72 from Patent WO2005071096
TGTATAC
>CS140616.1 Sequence 71 from Patent WO2005071096
TGGATAC
>CS140615.1 Sequence 70 from Patent WO2005071096
TGCATAC
>CS140614.1 Sequence 69 from Patent WO2005071096
TGAATAC
>CS140613.1 Sequence 68 from Patent WO2005071096
TCTATAC
>CS140612.1 Sequence 67 from Patent WO2005071096
TCGATAC
>CS140611.1 Sequence 66 from Patent WO2005071096
TCCATAC
>CS140610.1 Sequence 65 from Patent WO2005071096
TCAATAC
>CS140609.1 Sequence 64 from Patent WO2005071096
TATATAC
>CS140608.1 Sequence 63 from Patent WO2005071096
TAGATAC
>CS140607.1 Sequence 62 from Patent WO2005071096
TACATAC
>CS140606.1 Sequence 61 from Patent WO2005071096
TAAATAC
>CS140605.1 Sequence 60 from Patent WO2005071096
GTTATAC
>CS140604.1 Sequence 59 from Patent WO2005071096
GTGATAC
>CS140603.1 Sequence 58 from Patent WO2005071096
GTCATAC
>CS140602.1 Sequence 57 from Patent WO2005071096
GTAATAC
>CS140601.1 Sequence 56 from Patent WO2005071096
GGTATAC
>CS140600.1 Sequence 55 from Patent WO2005071096
GGGATAC
>CS140599.1 Sequence 54 from Patent WO2005071096
GGCATAC
>CS140598.1 Sequence 53 from Patent WO2005071096
GGAATAC
>CS140597.1 Sequence 52 from Patent WO2005071096
GCTATAC
>CS140596.1 Sequence 51 from Patent WO2005071096
GCGATAC
>CS140595.1 Sequence 50 from Patent WO2005071096
GCCATAC
>CS140594.1 Sequence 49 from Patent WO2005071096
GCAATAC
>CS140593.1 Sequence 48 from Patent WO2005071096
GATATAC
>CS140592.1 Sequence 47 from Patent WO2005071096
GACATAC
>CS140591.1 Sequence 46 from Patent WO2005071096
GACATAC
>CS140590.1 Sequence 45 from Patent WO2005071096
GAAATAC
>CS140589.1 Sequence 44 from Patent WO2005071096
CTTATAC
>CS140588.1 Sequence 43 from Patent WO2005071096
CTGATAC
>CS140587.1 Sequence 42 from Patent WO2005071096
CTCATAC
>CS140586.1 Sequence 41 from Patent WO2005071096
CTAATAC
>CS140585.1 Sequence 40 from Patent WO2005071096
CGGATAC
>CS140584.1 Sequence 39 from Patent WO2005071096
CGGATAC
>CS140583.1 Sequence 38 from Patent WO2005071096
CGCATAC
>CS140582.1 Sequence 37 from Patent WO2005071096
CGAATAC
>CS140581.1 Sequence 36 from Patent WO2005071096
CCTATAC
>CS140580.1 Sequence 35 from Patent WO2005071096
CCGATAC
>CS140579.1 Sequence 34 from Patent WO2005071096
CCCATAC
>CS140578.1 Sequence 33 from Patent WO2005071096
CCAATAC
>CS140577.1 Sequence 32 from Patent WO2005071096
CATATAC
>CS140576.1 Sequence 31 from Patent WO2005071096
CAGATAC
>CS140575.1 Sequence 30 from Patent WO2005071096
CACATAC
>CS140574.1 Sequence 29 from Patent WO2005071096
CAAATAC
>CS140573.1 Sequence 28 from Patent WO2005071096
ATTATAC
>CS140572.1 Sequence 27 from Patent WO2005071096
ATGATAC
>CS140571.1 Sequence 26 from Patent WO2005071096
ATCATAC
>CS140570.1 Sequence 25 from Patent WO2005071096
ATAATAC
>CS140569.1 Sequence 24 from Patent WO2005071096
AGTATAC
>CS140568.1 Sequence 23 from Patent WO2005071096
AGGATAC
>CS140567.1 Sequence 22 from Patent WO2005071096
AGCATAC
>CS140566.1 Sequence 21 from Patent WO2005071096
AGAATAC
>CS140565.1 Sequence 20 from Patent WO2005071096
ACTATAC
>CS140564.1 Sequence 19 from Patent WO2005071096
ACGATAC
>CS140563.1 Sequence 18 from Patent WO2005071096
ACCATAC
>CS140562.1 Sequence 17 from Patent WO2005071096
ACAATAC
>CS140561.1 Sequence 16 from Patent WO2005071096
AATATAC
>CS140560.1 Sequence 15 from Patent WO2005071096
AAGATAC
>CS140559.1 Sequence 14 from Patent WO2005071096
AACATAC
>CS140558.1 Sequence 13 from Patent WO2005071096
AAAATAC
>CS140557.1 Sequence 12 from Patent WO2005071096
TGCATAC
>CS140556.1 Sequence 11 from Patent WO2005071096
ACAATAC
>CS140555.1 Sequence 10 from Patent WO2005071096
GATATAC
>CS140554.1 Sequence 9 from Patent WO2005071096
GAAATAC
>CS140552.1 Sequence 7 from Patent WO2005071096
NNNATAC
>CS140551.1 Sequence 6 from Patent WO2005071096
TTTATAC
>CS140550.1 Sequence 5 from Patent WO2005071096
TTTATAC
>CS140548.1 Sequence 3 from Patent WO2005071096
GCAACTT
>CS132848.1 Sequence 24 from Patent WO2005063820
CTTAAGC
>CS132841.1 Sequence 17 from Patent WO2005063820
CCCGGGT
>CS121848.1 Sequence 53 from Patent WO2005059143
GGAGGGA
>CS121465.1 Sequence 44 from Patent WO2005059144
GAAAGGA
>CS121464.1 Sequence 43 from Patent WO2005059144
TATCATT
>CS181964.1 Sequence 8 from Patent WO2002038597
ATGGACA
>CS329952.1 Sequence 102 from Patent EP1674574
TGTCGYT
>CS329881.1 Sequence 31 from Patent EP1674574
CAACGTT
>CS319500.1 Sequence 51 from Patent WO2006000448
CCCGGGT
>DD260596.1 GENETIC ANALYSIS FOR STRATIFICATION OF CANCER RISK
AAGTTCG
>DD260595.1 GENETIC ANALYSIS FOR STRATIFICATION OF CANCER RISK
AAGTCCG
>DD265474.1 Recombinant Bovine Immunodeficiency Virus Based Gene Transfer System
AAAAAAC
>DD265473.1 Recombinant Bovine Immunodeficiency Virus Based Gene Transfer System
CAAAAAT
>DD265472.1 Recombinant Bovine Immunodeficiency Virus Based Gene Transfer System
GGGAAAC
>DD265471.1 Recombinant Bovine Immunodeficiency Virus Based Gene Transfer System
AAAAAAC
>DD265470.1 Recombinant Bovine Immunodeficiency Virus Based Gene Transfer System
TTTTTTA
>DD265469.1 Recombinant Bovine Immunodeficiency Virus Based Gene Transfer System
AAATTTA
>DD272193.1 SPLICEOSOME-MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF SKIN DISORDERS
TGTCAGG
>DD272189.1 SPLICEOSOME-MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF SKIN DISORDERS
TGTCAGG
>DD272188.1 SPLICEOSOME-MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF SKIN DISORDERS
TCTGTCA
>DD272179.1 SPLICEOSOME-MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF SKIN DISORDERS
TACTAAC
>DD272157.1 SPLICEOSOME-MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF SKIN DISORDERS
YNYTRAC
>A58617.1 Sequence 23 from Patent EP0754700
ACTTACG
>A58023.1 Sequence 32 from Patent EP0745691
CTTTGTG
>A47239.1 Sequence 13 from Patent WO9530000
GGGAGAA
>A43358.1 Sequence 2 from Patent WO9505471
TATCCTG
>A41029.1 Sequence 16 from Patent EP0626449
AAAATAT
>A15260.1 Oligonucleotide N'
CGATACC
>A16494.1 oligonucleotide N'
CGATACC
>BD357224.1 84P2A9: PROSTATE AND TESTIS SPECIFIC PROTEIN HIGHLY EXPRESSED IN PROSTATE CANCER
AACATGG
>DD050779.1 Screening and activity-measurement method for protein which regulates transcription reaction
TATAAAA
>DD050772.1 Screening and activity-measurement method for protein which regulates transcription reaction
AGGAAAA
>DD146127.1 Surface Transfection and Expression Procedure
TGACTCA
>DD030151.1 METHOD OF PERFORMING SUBTRACTIVE HYBRIDIZATION
GAATTCG
>BD314009.1 Method of making plant artificial chromosomes
TTTAGGG
>BD314008.1 Method of making plant artificial chromosomes
TTTAGGG
>BD277507.1 New single nucleotide polymorphism of IL-4 gene for allergic risk factor and the use thereof
CTTTTGC
>BD277452.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
GGCTATC
>BD277442.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
AGTGGAC
>BD277433.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
GTTGAAC
>BD277428.1 Single nucleotide polymorphism-markers for allergic risk factor and the use thereof
ACTGGGG
>BD411274.1 A simple method to identify normal cytoplasm from the BT-type cytoplasmic male sterility in rice
TTCCCTC
>BD432704.1 HPV-SPECIFIC SHORT-MERS
TCCGCCA
>BD432678.1 HPV-SPECIFIC SHORT-MERS
GTACCTG
>BD388849.1 A method for identifying chemical shifts of a multiple complex, a method for analyzing the steric structure of a multiple complex, a method for constructing a model of a multiple complex, novel nucleic acid molecules and reagents
TAGGGTT
>BD300170.1 Methods and means for producing high titer, safe, recombinant lentivirus vectors
CTGATCA
>DD085102.1 In Vitro Methods Of Producing And Identifying Immunoglobulin Molecules In Eukaryotic Cells
GGTCACC
>DD069985.1 Oligonucleotide Conjugates
GGGTTAG
>DD099113.1 A novel protein and DNA encoding it
TATAAAA
>DD099106.1 A novel protein and DNA encoding it
AGGAAAA
>BD410068.1 GENETIC VACCINE THAT MIMICS NATURAL VIRAL INFECTION AND INDUCES LONG-LASTING IMMUNITY TO PATHOGENS
AAAAAAA
>BD410066.1 GENETIC VACCINE THAT MIMICS NATURAL VIRAL INFECTION AND INDUCES LONG-LASTING IMMUNITY TO PATHOGENS
TTTTTTT
>BD410065.1 GENETIC VACCINE THAT MIMICS NATURAL VIRAL INFECTION AND INDUCES LONG-LASTING IMMUNITY TO PATHOGENS
TTTTTTT
>BD322222.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGGGGBG
>BD322195.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGGTCCG
>BD322170.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CBCGCGG
>BD322152.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CBGGGGC
>BD322145.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GCTCCGG
>BD322120.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGGCCCC
>BD322110.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CCGGGGC
>BD322102.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CCBCCBG
>BD322096.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGGGCCG
>BD322091.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CCGGTGG
>BD322076.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CCGTGTC
>BD322067.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
TCTGCGC
>BD322065.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
TTCCTTC
>BD322062.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GCCCCGC
>BD322046.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CTGTCGT
>BD322033.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
TTCCTGT
>BD322027.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GGCBGGG
>BD322021.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
GTCCCTC
>BD322012.1 Low-adenosine antisense oligonucleotide, its composition, kit and method for treating respiratory tract disorder related to bronchoconstriction, pneumonia, allergy and surfactant depletion
CCCTTGG
>DD098209.1 Templated molecules and methods for using such molecules
CACNGAA
>BD292054.1 Lactose operon of lactobacillus delbrueckii and its uses for controlling gene transcription and/or expression in bacterial cell
GTAAACG
>BD292053.1 Lactose operon of lactobacillus delbrueckii and its uses for controlling gene transcription and/or expression in bacterial cell
GTAAACA
>BD419838.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
TCAACGT
>BD419479.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
CAACGTT
>BD419364.1 Methods for Enhancing Antibody-Induced Cell Lysis and Treating Cancer
AACGTTG
>BD291415.1 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
ACTGGTT
>BD375401.1 TRAIT-ASSOCIATED GENE IDENTIFICATION METHOD
AGATCCC
>BD300499.1 Template-dependent ligation with the use of PNA-DNA chimeric probe
TAGTTCT
>BD418977.1 PROMOTERS FOR REGULATED GENE EXPRESSION
GAGTTTT
>DD139338.1 TGF-beta activity controlling agent
TTCTTAC
>DD057029.1 Statistical Analysis Of Regulatory Factor Binding Sites Of Differentially Expressed Genes
TGACTCA
>DD019675.1 Medicine for inhibiting production of MMP-9
TGAGCAT
>DD102620.1 CLASP-2 Transmembrane Proteins
RNNATGG
>DD094876.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNGCC
>DD094875.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNACG
>DD094856.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGANGGC
>DD094850.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNGAG
>DD094816.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNTGC
>DD094785.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
ACGNCCC
>DD094781.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GAGNCCC
>DD094756.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNCCC
>DD094743.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNAGG
>DD094729.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGGNCCC
>DD094715.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCANCCC
>DD094714.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNGGA
>DD094703.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNCCA
>DD094668.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNGCC
>DD094619.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNCGG
>DD094603.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNTGC
>BD373821.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CTTGCTT
>BD373820.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CTTGCTG
>BD373819.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CATGCTG
>BD373818.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CAAGCTG
>BD373817.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CATACTG
>BD373816.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CATGCTG
>BD373815.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CATACTV
>BD373814.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CATATTG
>BD373813.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CATACTA
>BD373812.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CATACTT
>BD373811.1 AIDS ANCESTRAL VIRUSES AND VACCINES
CATACTC
>BD373810.1 AIDS ANCESTRAL VIRUSES AND VACCINES
GAWACTC
>BD373809.1 AIDS ANCESTRAL VIRUSES AND VACCINES
GATACTC
>BD373808.1 AIDS ANCESTRAL VIRUSES AND VACCINES
GAAACTC
>BD373807.1 AIDS ANCESTRAL VIRUSES AND VACCINES
GAACCTG
>BD373806.1 AIDS ANCESTRAL VIRUSES AND VACCINES
GAWCCTG
>BD373805.1 AIDS ANCESTRAL VIRUSES AND VACCINES
GATCCTG
>DD094538.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGCNGCC
>DD094509.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GGCNCCC
>DD094466.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGCNCCC
>DD094453.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNCGC
>DD094407.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCANCGC
>DD094388.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNACC
>DD094387.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNCGG
>DD094381.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNGCC
>DD094372.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CTGNCCC
>DD136840.1 A Method for Stabilizing Phospholipase D
CGGATCC
>BD319370.1 Therapeutically Useful Synthetic Oligonucleotides
GGGTGGT
>BD319369.1 Therapeutically Useful Synthetic Oligonucleotides
TGGGTGG
>BD319368.1 Therapeutically Useful Synthetic Oligonucleotides
GGGTGGG
>BD319367.1 Therapeutically Useful Synthetic Oligonucleotides
GGGGTGG
>DD094366.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGGNCGC
>DD094364.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNGGC
>DD094338.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCGNACC
>DD094331.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNCCC
>DD094322.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GCCNCGC
>DD094294.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
AGCNGCG
>DD094284.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNCCG
>DD094281.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNGGC
>DD094273.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCANCGG
>DD094268.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCGNCAG
>DD094253.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CAGNGGG
>DD094239.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNGCA
>DD094221.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
GGANCCC
>DD094211.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGGNGCC
>DD094187.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNCCC
>DD094184.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CGCNGAC
>DD136540.1 Proteins and DNAs encoding them
TATAAAA
>DD136533.1 Proteins and DNAs encoding them
AGGAAAA
>DD033738.1 A novel protein and DNA encoding it
TATAAAA
>DD033731.1 A novel protein and DNA encoding it
AGGAAAA
>DD111856.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
TGACTTG
>DD111855.1 Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
TGACTCA
>BD325726.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGGGGBG
>BD325699.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGGTCCG
>BD325674.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CBCGCGG
>BD325656.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CBGGGGC
>BD325649.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GCTCCGG
>BD325624.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGGCCCC
>BD325614.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CCGGGGC
>BD325606.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CCBCCBG
>BD325550.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CTGTCGT
>BD325537.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
TTCCTGT
>BD325531.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGCBGGG
>BD325525.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GTCCCTC
>BD325516.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CCCTTGG
>DD090117.1 Medicine for inhibiting production of MMP-9
TGAGCAT
>BD272376.1 Assay for identifying compound affecting the stability of mRNA
TATTTAT
>BD270815.1 Stereoisomer of CpG oligonucleotide and method relating thereto
TGTCGYT
>BD395680.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
CAGGAAG
>BD395679.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
GAGGAAA
>BD395674.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
CAGGAAG
>BD395655.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
CTGGATG
>BD395654.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
CTGGAAG
>BD395653.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
GTGGATG
>BD395652.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
GTGGAAG
>BD395632.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
CAGGATG
>BD395631.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
CAGGAAG
>BD395630.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
GAGGATG
>BD395601.1 NUCLEOTIDE SEQUENCES FOR GENE REGULATION AND METHODS OF USE THEREOF
GAGGAAG
>DD094168.1 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using DNA sequences
CCCNGCG
>DD135102.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
CAACGTT
>DD148541.1 A method to detect existence of a target deoxyribonucleic acid by amplification of a nucleic acid signal, and a detection method and quantitative method of an immunological ligand
ACTGGAT
>BD318783.1 COMPOSITIONS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
TGCAATC
>BD318751.1 COMPOSITIONS AND METHODS FOR TREATMENT AND DIAGNOSIS OF CHLAMYDIAL INFECTION
TGCAATC
>DD135183.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
TGTCGTT
>DD135182.1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
TGTCGCT
>DD047425.1 Novel Proteins and DNAs Coding Them
TATAAAA
>DD047418.1 Novel Proteins and DNAs Coding Them
AGGAAAA
>BD297771.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
TGTCGYT
>DD031269.1 GENE DELIVERY FORMULATION AND METHOD FOR TREATMENT OF ISCHEMIC CONDITIONS
TACTAAC
>BD297709.1 Methods Related to Immunostimulatory Nucleic Acid-Induced Interferon
CAACGTT
>BD445182.1 Production of Secreted Polypeptides
ACAGAAT
>BD445181.1 Production of Secreted Polypeptides
ACAGTAT
>BD445180.1 Production of Secreted Polypeptides
ACAGAAT
>BD325600.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GGGGCCG
>BD325595.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CCGGTGG
>BD325580.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
CCGTGTC
>BD325571.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
TCTGCGC
>BD325569.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
TTCCTTC
>BD325566.1 Nucleic acid for multiple-target hybridization, its preparation, composition, formulation, kit and application
GCCCCGC
>DD241008.1 Parallel Stranded Duplexes of Deoxyribonucleic Acid and Methods of Use
TCCTCCT
>DD240963.1 A NEW METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF MALIGNANT DISEASES
GCATGCT
>DD253146.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNGCC
>DD253145.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNACG
>DD253126.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGANGGC
>DD253120.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNGAG
>DD253086.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNTGC
>DD253055.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
ACGNCCC
>DD253051.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GAGNCCC
>DD253026.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNCCC
>DD253013.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNAGG
>DD252999.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNCCC
>DD252985.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANCCC
>DD252984.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNGGA
>DD252973.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNCCA
>DD240570.1 SPLICEOSOME MEDIATED RNA TRANS-SPLICING FOR CORRECTION OF FACTOR VIII GENETIC DEFECTS USING SPLICEOSOME MEDIATED RNA TRANS SPLICING
YNYTRAC
>DD252938.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNGCC
>DD252889.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNCGG
>DD252873.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNTGC
>DD252808.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNGCC
>DD252779.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGCNCCC
>DD252736.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNCCC
>DD252723.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNCGC
>DD252677.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCANCGC
>DD252658.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNACC
>DD252657.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNCGG
>DD252651.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNGCC
>DD252642.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CTGNCCC
>DD252636.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGGNCGC
>DD252634.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNGGC
>DD252608.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCGNACC
>DD252601.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNCCC
>DD252592.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GCCNCGC
>DD252564.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
AGCNGCG
>DD252554.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNCCG
>DD252551.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNGGC
>DD252543.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCANCGG
>DD252538.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCGNCAG
>DD252523.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CAGNGGG
>DD252509.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNGCA
>DD252491.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
GGANCCC
>DD252481.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGGNGCC
>DD252457.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNCCC
>DD252454.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CGCNGAC
>DD252438.1 A method for simultaneous production of multiple proteins; vectors and cells for use therein
CCCNGCG
>DD251161.1 Compound Screening
TATTTAT
>DD251120.1 A METHOD FOR THE DETECTION OF APOPTOSIS
GCATGCT
>DD238024.1 A gene encoding a guanine nucleotide exchange factor and the gene product thereof
CACCATG
>DD236666.1 A gene encoding a guanine nucleotide exchange factor and the gene product thereof
CACCATG
>DD235047.1 Method for producing cyclic single-stranded DNA and method for determining polynucleotide sequence to be used in production of cyclic single-stranded DNA
CACACCG
>DD235046.1 Method for producing cyclic single-stranded DNA and method for determining polynucleotide sequence to be used in production of cyclic single-stranded DNA
CCGGCGC
>DD246865.1 SPLICEOSOME MEDIATED RNA TRANS-SPLICING IN STEM CELLS
YNYTRAC
>DD257717.1 ALTERNATIVELY SPLICED NUCLEIC ACID MOLECULES
CCCTGAG
>DD257716.1 ALTERNATIVELY SPLICED NUCLEIC ACID MOLECULES
ACCTTAC
>DD257711.1 ALTERNATIVELY SPLICED NUCLEIC ACID MOLECULES
CACTGAC
>DD257710.1 ALTERNATIVELY SPLICED NUCLEIC ACID MOLECULES
CTTTTAC
>DD257708.1 ALTERNATIVELY SPLICED NUCLEIC ACID MOLECULES
YNYTRAC
>DD257516.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
GGACGTT
>DD257495.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
GCTCACT
>DD257483.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
TGTTGAA
>DD257467.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
ATTATCT
>DD257463.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
ATTATCT
>DD257444.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
GGATACA
>DD257439.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
GCTCACT
>DD257433.1 ANTIBODIES DIRECTED TO PDGFD AND USES THEREOF
TACTACT
>BD273170.1 Expression vectors comprising multiple shear stress responsive elements (SSRE) and a gene of interest and methods of use thereof
TGACTCC
>BD270752.1 Stereoisomer of CpG oligonucleotide and method relating thereto
CAACGTT
>E02386.1 DNA probe for detecting protein concerned in recombination of immunoglobulin gene and Tcell antigen receptor gene
YACTGTG
>E00746.1 Synthetic DNA of promoter (-10 region)
GTATAAT
>E00744.1 Synthetic DNA of promoter(-35 region)
TTGACAT
>E00364.1 Internal sequence of enhancer of human omtibody gene
AAAACAC
>E09488.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
TTGGAGG
>E09487.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
TGGGAGG
>E09486.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
TGGGAGA
>E09485.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
TGCGAGG
>E09484.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
TCGGAGG
>E09483.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
TAGGAGG
>E09482.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
GGGGAGG
>E09481.1 Phosphorothioate-bound oligodeoxynucleotide which inhibits HIV-1 growth
CGGGAGG
>E09367.1 The recognition sequence of a novel restriction enzyme Sse 1825I
GGGWCCC
>E09172.1 Synthetic oligonucleotides for anti-HIV agent
TTGGAGG
>E09171.1 Synthetic oligonucleotides for anti-HIV agent
TGGGAGG
>E09170.1 Synthetic oligonucleotides for anti-HIV agent
TGGGAGA
>E09169.1 Synthetic oligonucleotides for anti-HIV agent
TGCGAGG
>E09168.1 Synthetic oligonucleotides for anti-HIV agent
TCGGAGG
>E09167.1 Synthetic oligonucleotides for anti-HIV agent
TAGGAGG
>E09166.1 Synthetic oligonucleotides for anti-HIV agent
GGGGAGG
>E09165.1 Synthetic oligonucleotides for anti-HIV agent
CGGGAGG
>E17124.1 Pythium sp. - specific sequence in 18S rRNA gene
TAAATCG
>E17085.1 Rhizoctonia sp. - specific sequence in 18S rRNA gene
CGACTCT
>E17079.1 Fusarium sp. - specific sequence in 18S rRNA gene
CCAGAGA
>E14979.1 AP-1-binding sequence
TGAGTCA
>E14756.1 Preferable sequence for protein over expression that should be located between SD sequence and start codon
ATCGGGC
>E07878.1 Synthetic nucleotides for DNA binding protein analysis
TGAGTCA
>DD228520.1 Human Chronic Lymphocytic Leukemia Modeled In Mouse By Targeted TCL1 Expression
TAGTAGC
>DD227553.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
AGGTAAG
>DD227504.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
AAAAAAA
>DD227502.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
TTTTTTT
>DD227501.1 GENETIC VACCINE AGAINST HUMAN IMMUNODEFICIENCY VIRUS
TTTTTTT
>DD224713.1 Qualitative analysis method of arylhydrocarbon receptor ligands
TNGCGTG
>DD223375.1 Reporter Construct comprising XRE Sequence
TTGCGTG
>DD221652.1 Manipulation of Cytokine Levels using CD83 Gene Products
ATTTTTA
>DD217458.1 THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE
ASTHMAM
>DD219523.1 Method to Inhibit Cell Growth Using Oligonucleotides
AGTATGA
>DD219519.1 Method to Inhibit Cell Growth Using Oligonucleotides
AGTATGA
>DD217801.1 METHOD OF TREATING AMINO ACID METABOLIC DISORDERS USING RECOMBINANT ADENO-ASSOCIATED VIRUS VIRIONS
GGGGGGG
>DD217800.1 METHOD OF TREATING AMINO ACID METABOLIC DISORDERS USING RECOMBINANT ADENO-ASSOCIATED VIRUS VIRIONS
TATTTAA
>AX358377.1 Sequence 4 from Patent WO0191536
AAAAAAA
>AX358375.1 Sequence 2 from Patent WO0191536
TTTTTTT
>AX358374.1 Sequence 1 from Patent WO0191536
TTTTTTT
>DD211558.1 Vaccine
TTTTTNT
>DD192128.1 Apparatus and method for determining a biological sample, and Plate for detemining a biological sample
TAACGGT
>DD192127.1 Apparatus and method for determining a biological sample, and Plate for detemining a biological sample
ACGCGAT
>DD192126.1 Apparatus and method for determining a biological sample, and Plate for detemining a biological sample
ATCGCGT
>DD211076.1 Nanostructures Containing PNA Joining or Functional Elements
GAAGGAG
>DD211075.1 Nanostructures Containing PNA Joining or Functional Elements
AGAGAGA
>DD211074.1 Nanostructures Containing PNA Joining or Functional Elements
GGGAAAA
>DD211073.1 Nanostructures Containing PNA Joining or Functional Elements
GGGGGGG
>DD182501.1 An agent for regulating angiogenesis
GBGGGGG
>DD210392.1 COMPOSITIONS AND METHODS FOR SURROGATE ANTIBODY MODULATION OF AN IMMUNE RESPONSE AND TRANSPORT
TGTCGYT
>DD210391.1 COMPOSITIONS AND METHODS FOR SURROGATE ANTIBODY MODULATION OF AN IMMUNE RESPONSE AND TRANSPORT
TGACGTT
>DD190749.1 Probe set and method for identification of allele of HLA
ACCCAAC
>DD195298.1 High Resolution Typing System For Pathogenic E Coli
AGTTGCA
>DD195297.1 High Resolution Typing System For Pathogenic E Coli
TGCAACT
>DD195290.1 High Resolution Typing System For Pathogenic E Coli
GTGAGGT
>DD195289.1 High Resolution Typing System For Pathogenic E Coli
ACCTCAC
>DD172179.1 NF-kappaB Oligonucleotide Decoy Molecules
CCTTGAA
>DD172124.1 NF-kappaB Oligonucleotide Decoy Molecules
GATTTCC
>DD172107.1 NF-kappaB Oligonucleotide Decoy Molecules
CCTTGAA
>CS120593.1 Sequence 79 from Patent WO2005056020
CCTTGAA
>CS120537.1 Sequence 23 from Patent WO2005056020
GATTTCC
>CS120463.1 Sequence 14 from Patent WO2005056807
AGTGTGG
>CS101298.1 Sequence 14 from Patent EP1536024
AAACCCA
>CS101297.1 Sequence 13 from Patent EP1536024
TAACCCA
>CS098108.1 Sequence 90 from Patent WO2000075279
CAGGAAG
>CS098107.1 Sequence 89 from Patent WO2000075279
GAGGAAA
>CS098102.1 Sequence 84 from Patent WO2000075279
GCGGAAG
>CS098083.1 Sequence 65 from Patent WO2000075279
CTGGATG
>CS098082.1 Sequence 64 from Patent WO2000075279
CTGGAAG
>CS098081.1 Sequence 63 from Patent WO2000075279
GTGGATG
>CS098080.1 Sequence 62 from Patent WO2000075279
GTGGAAG
>CS098059.1 Sequence 41 from Patent WO2000075279
CAGGATG
>CS098058.1 Sequence 40 from Patent WO2000075279
CAGGAAG
>CS098057.1 Sequence 39 from Patent WO2000075279
GAGGATG
>CS098020.1 Sequence 2 from Patent WO2000075279
GAGGAAG
>CS097998.1 Sequence 36 from Patent WO2005037323
GCATGCT
>CS077917.1 Sequence 35 from Patent WO2005035579
GCATGCT
>CS077238.1 Sequence 28 from Patent WO2005035547
TTTCCGG
>CS008056.1 Sequence 24 from Patent WO2005007889
CTTTGAT
>CQ970095.1 Sequence 56 from Patent WO2004106375
GGTNACC
>CQ892394.1 Sequence 3 from Patent WO2004087965
TGACTCA
>CQ892045.1 Sequence 88 from Patent WO2004087203
TGTCGNT
>CQ891982.1 Sequence 25 from Patent WO2004087203
CAACGTT
>CQ891732.1 Sequence 14 from Patent WO2004087201
TTTTTNT
>CQ881418.1 Sequence 17 from Patent WO2004083427
ATGTCAT
>CQ881417.1 Sequence 16 from Patent WO2004083427
ACTTGAT
>CQ881416.1 Sequence 15 from Patent WO2004083427
AACNACT
>CQ881415.1 Sequence 14 from Patent WO2004083427
TACNACA
>CQ881414.1 Sequence 13 from Patent WO2004083427
TACNACA
>CQ881410.1 Sequence 9 from Patent WO2004083427
ATCNGTA
>CQ881409.1 Sequence 8 from Patent WO2004083427
ATGNCAT
>CQ881405.1 Sequence 4 from Patent WO2004083427
ANNNNNT
>CQ881404.1 Sequence 3 from Patent WO2004083427
TNNNNNA
>CQ881403.1 Sequence 2 from Patent WO2004083427
ANNANNT
>CQ881402.1 Sequence 1 from Patent WO2004083427
TNNANNA
>CQ857585.1 Sequence 2 from Patent WO2004070041
CTTTGNN
>CQ831870.1 Sequence 5 from Patent WO2004056996
CAGGATG
>CQ830818.1 Sequence 21 from Patent EP1431303
GGAATTC
>CQ829024.1 Sequence 742 from Patent WO2004053120
CTAAGTG
>CQ829022.1 Sequence 740 from Patent WO2004053120
GTAAGTG
>CQ828991.1 Sequence 709 from Patent WO2004053120
TGAAGTG
>CQ828935.1 Sequence 653 from Patent WO2004053120
TCAAGTG
>CQ828925.1 Sequence 643 from Patent WO2004053120
CTAAGTG
>CQ828913.1 Sequence 631 from Patent WO2004053120
CCAAGTG
>CQ828900.1 Sequence 618 from Patent WO2004053120
TCAAGTG
>CQ828833.1 Sequence 551 from Patent WO2004053120
CTAAGTG
>CQ828787.1 Sequence 505 from Patent WO2004053120
TGAAGTG
>CQ828757.1 Sequence 475 from Patent WO2004053120
GTAAGTG
>CQ828750.1 Sequence 468 from Patent WO2004053120
TGAAGTG
>CQ828746.1 Sequence 464 from Patent WO2004053120
TGAAGTG
>CQ828661.1 Sequence 379 from Patent WO2004053120
CTAAGTG
>CQ828567.1 Sequence 285 from Patent WO2004053120
GTAAGTG
>CQ828509.1 Sequence 227 from Patent WO2004053120
TGAAGTG
>CQ828482.1 Sequence 200 from Patent WO2004053120
CCAAGTG
>CQ828441.1 Sequence 159 from Patent WO2004053120
TGAAGTG
>CQ818607.1 Sequence 37 from Patent WO2004039825
GCAGCCA
>CQ818606.1 Sequence 36 from Patent WO2004039825
TCGAGCG
>CQ800494.1 Sequence 30 from Patent EP1411124
GACATGT
>CQ800493.1 Sequence 29 from Patent EP1411124
GAGATGA
>CQ800480.1 Sequence 16 from Patent EP1411124
GATATGG
>AL112610.1 Botrytis cinerea strain T4 cDNA library
CGCACAT
>CQ771716.1 Sequence 8 from Patent WO2004009824
NATATTN
>CQ771710.1 Sequence 2 from Patent WO2004009824
NATTTTN
>CQ771709.1 Sequence 1 from Patent WO2004009824
NAAATTN
>CQ771565.1 Sequence 2 from Patent EP1138781
TATAAAA
>CQ766097.1 Sequence 58 from Patent WO2004005547
AAAGACG
>CQ766096.1 Sequence 57 from Patent WO2004005547
AAAGACG
>CQ766095.1 Sequence 56 from Patent WO2004005547
AAAGACG
>CQ758794.1 Sequence 1098 from Patent WO2003106684
CAGNGCC
>CQ758793.1 Sequence 1097 from Patent WO2003106684
CCCNACG
>CQ758774.1 Sequence 1078 from Patent WO2003106684
AGANGGC
>CQ758768.1 Sequence 1072 from Patent WO2003106684
CCCNGAG
>CQ758734.1 Sequence 1038 from Patent WO2003106684
CCGNTGC
>CQ758703.1 Sequence 1007 from Patent WO2003106684
ACGNCCC
>CQ758699.1 Sequence 1003 from Patent WO2003106684
GAGNCCC
>CQ758674.1 Sequence 978 from Patent WO2003106684
CCGNCCC
>CQ758661.1 Sequence 965 from Patent WO2003106684
CCGNAGG
>CQ758647.1 Sequence 951 from Patent WO2003106684
AGGNCCC
>CQ758633.1 Sequence 937 from Patent WO2003106684
CCANCCC
>CQ758632.1 Sequence 936 from Patent WO2003106684
CGCNGGA
>CQ758621.1 Sequence 925 from Patent WO2003106684
GCGNCCA
>CQ758586.1 Sequence 890 from Patent WO2003106684
CCCNGCC
>CQ758537.1 Sequence 841 from Patent WO2003106684
CCCNCGG
>CQ758521.1 Sequence 825 from Patent WO2003106684
CGGNTGC
>CQ758456.1 Sequence 760 from Patent WO2003106684
AGCNGCC
>CQ758427.1 Sequence 731 from Patent WO2003106684
GGCNCCC
>CQ758384.1 Sequence 688 from Patent WO2003106684
AGCNCCC
>CQ758371.1 Sequence 675 from Patent WO2003106684
CCCNCGC
>CQ758325.1 Sequence 629 from Patent WO2003106684
GCANCGC
>CQ758306.1 Sequence 610 from Patent WO2003106684
CCCNACC
>CQ758305.1 Sequence 609 from Patent WO2003106684
CCGNCGG
>CQ758299.1 Sequence 603 from Patent WO2003106684
CGCNGCC
>CQ758290.1 Sequence 594 from Patent WO2003106684
CTGNCCC
>CQ758284.1 Sequence 588 from Patent WO2003106684
AGGNCGC
>CQ758282.1 Sequence 586 from Patent WO2003106684
CGGNGGC
>CQ758256.1 Sequence 560 from Patent WO2003106684
GCGNACC
>CQ758249.1 Sequence 553 from Patent WO2003106684
CGGNCCC
>CQ758240.1 Sequence 544 from Patent WO2003106684
GCCNCGC
>CQ758212.1 Sequence 516 from Patent WO2003106684
AGCNGCG
>CQ758202.1 Sequence 506 from Patent WO2003106684
CCCNCCG
>CQ758199.1 Sequence 503 from Patent WO2003106684
CGCNGGC
>CQ758191.1 Sequence 495 from Patent WO2003106684
CCANCGG
>CQ758186.1 Sequence 490 from Patent WO2003106684
CCGNCAG
>CQ758171.1 Sequence 475 from Patent WO2003106684
CAGNGGG
>CQ758157.1 Sequence 461 from Patent WO2003106684
CGGNGCA
>CQ758139.1 Sequence 443 from Patent WO2003106684
GGANCCC
>CQ758129.1 Sequence 433 from Patent WO2003106684
CGGNGCC
>CQ758105.1 Sequence 409 from Patent WO2003106684
CCCNCCC
>CQ758102.1 Sequence 406 from Patent WO2003106684
CGCNGAC
>CQ758086.1 Sequence 390 from Patent WO2003106684
CCCNGCG
>CQ756652.1 Sequence 81 from Patent WO2003104276
CTTTGGC
>CQ756556.1 Sequence 1057 from Patent WO2003106674
CAGNGCC
>CQ756555.1 Sequence 1056 from Patent WO2003106674
CCCNACG
>CQ756536.1 Sequence 1037 from Patent WO2003106674
AGANGGC
>CQ756530.1 Sequence 1031 from Patent WO2003106674
CCCNGAG
>CQ756496.1 Sequence 997 from Patent WO2003106674
CCGNTGC
>CQ756465.1 Sequence 966 from Patent WO2003106674
ACGNCCC
>CQ756461.1 Sequence 962 from Patent WO2003106674
GAGNCCC
>CQ756436.1 Sequence 937 from Patent WO2003106674
CCGNCCC
>CQ756423.1 Sequence 924 from Patent WO2003106674
CCGNAGG
>CQ756409.1 Sequence 910 from Patent WO2003106674
AGGNCCC
>CQ756395.1 Sequence 896 from Patent WO2003106674
CCANCCC
>CQ756394.1 Sequence 895 from Patent WO2003106674
CGCNGGA
>CQ756383.1 Sequence 884 from Patent WO2003106674
GCGNCCA
>CQ756348.1 Sequence 849 from Patent WO2003106674
CCCNGCC
>CQ756299.1 Sequence 800 from Patent WO2003106674
CCCNCGG
>CQ756283.1 Sequence 784 from Patent WO2003106674
CGGNTGC
>CQ756218.1 Sequence 719 from Patent WO2003106674
AGCNGCC
>CQ756189.1 Sequence 690 from Patent WO2003106674
GGCNCCC
>CQ756146.1 Sequence 647 from Patent WO2003106674
AGCNCCC
>CQ756133.1 Sequence 634 from Patent WO2003106674
CCCNCGC
>CQ756087.1 Sequence 588 from Patent WO2003106674
GCANCGC
>CQ756068.1 Sequence 569 from Patent WO2003106674
CCCNACC
>CQ756067.1 Sequence 568 from Patent WO2003106674
CCGNCGG
>CQ756061.1 Sequence 562 from Patent WO2003106674
CGCNGCC
>CQ756052.1 Sequence 553 from Patent WO2003106674
CTGNCCC
>CQ756046.1 Sequence 547 from Patent WO2003106674
AGGNCGC
>CQ756044.1 Sequence 545 from Patent WO2003106674
CGGNGGC
>CQ756018.1 Sequence 519 from Patent WO2003106674
GCGNACC
>CQ756011.1 Sequence 512 from Patent WO2003106674
CGGNCCC
>CQ756002.1 Sequence 503 from Patent WO2003106674
GCCNCGC
>CQ755974.1 Sequence 475 from Patent WO2003106674
AGCNGCG
>CQ755964.1 Sequence 465 from Patent WO2003106674
CCCNCCG
>CQ755961.1 Sequence 462 from Patent WO2003106674
CGCNGGC
>CQ755953.1 Sequence 454 from Patent WO2003106674
CCANCGG
>CQ755948.1 Sequence 449 from Patent WO2003106674
CCGNCAG
>CQ755933.1 Sequence 434 from Patent WO2003106674
CAGNGGG
>CQ755919.1 Sequence 420 from Patent WO2003106674
CGGNGCA
>CQ755901.1 Sequence 402 from Patent WO2003106674
GGANCCC
>CQ755891.1 Sequence 392 from Patent WO2003106674
CGGNGCC
>CQ755867.1 Sequence 368 from Patent WO2003106674
CCCNCCC
>CQ755864.1 Sequence 365 from Patent WO2003106674
CGCNGAC
>CQ755848.1 Sequence 349 from Patent WO2003106674
CCCNGCG
>CQ427100.1 Sequence 12134 from Patent WO0151628
GCGGGAG
>AX958286.1 Sequence 16 from Patent WO03087815
TATTTAT
>AX934364.1 Sequence 4 from Patent EP1357184
TCTCTTA
>AX933967.1 Sequence 76 from Patent WO03087409
CGGWCCG
>AX933966.1 Sequence 75 from Patent WO03087409
RGGWCCY
>AX933939.1 Sequence 48 from Patent WO03087409
RGGTCCY
>AX933938.1 Sequence 47 from Patent WO03087409
RGGACCY
>AX930367.1 Sequence 6 from Patent WO03087369
CTGATGA
>AX930356.1 Sequence 7 from Patent WO03087383
GGGGGGG
>AX930355.1 Sequence 6 from Patent WO03087383
TATTTAA
>AX923455.1 Sequence 32 from Patent WO03080816
CTTTGTT
>AX923453.1 Sequence 30 from Patent WO03080816
CTTTGTT
>AX827234.1 Sequence 12 from Patent WO03074734
GGGACGT
>AX825542.1 Sequence 2 from Patent WO03073105
GGRGGCC
>AX816842.1 Sequence 133 from Patent WO03014390
TTAATAA
>AX816841.1 Sequence 132 from Patent WO03014390
ATAATAA
>AX816840.1 Sequence 131 from Patent WO03014390
TGAATAA
>AX816839.1 Sequence 130 from Patent WO03014390
AGAATAA
>AX816838.1 Sequence 129 from Patent WO03014390
TTAAGAA
>AX816837.1 Sequence 128 from Patent WO03014390
ATAAGAA
>AX816836.1 Sequence 127 from Patent WO03014390
TGAAGAA
>AX816835.1 Sequence 126 from Patent WO03014390
AGAAGAA
>AX816716.1 Sequence 4 from Patent WO02085340
CCCACCC
>AX805880.1 Sequence 26 from Patent WO03060163
GGTGGAG
>AX805879.1 Sequence 25 from Patent WO03060163
GGTTGGT
>AX805878.1 Sequence 24 from Patent WO03060163
GTGTTAA
>AX805877.1 Sequence 23 from Patent WO03060163
TTAATAA
>AX805876.1 Sequence 22 from Patent WO03060163
CCTGCGT
>AX805875.1 Sequence 21 from Patent WO03060163
CACCGCT
>AX805874.1 Sequence 20 from Patent WO03060163
CCCACCA
>AX805873.1 Sequence 19 from Patent WO03060163
CCCTCCC
>AX799759.1 Sequence 7 from Patent WO03030656
GGGNGGG
>AX798897.1 Sequence 34 from Patent WO03054005
AAGATGC
>BD194488.1 Peptide inducing the formation of compact structure
NNNATGG
>AX786657.1 Sequence 148 from Patent WO03030934
GGGNGGG
>AX786597.1 Sequence 88 from Patent WO03030934
TGTCGYT
>AX786534.1 Sequence 25 from Patent WO03030934
CAACGTT
>AX765594.1 Sequence 1064 from Patent WO03004704
CAGNGCC
>AX765593.1 Sequence 1063 from Patent WO03004704
CCCNACG
>AX765574.1 Sequence 1044 from Patent WO03004704
AGANGGC
>AX765568.1 Sequence 1038 from Patent WO03004704
CCCNGAG
>AX765534.1 Sequence 1004 from Patent WO03004704
CCGNTGC
>AX765503.1 Sequence 973 from Patent WO03004704
ACGNCCC
>AX765499.1 Sequence 969 from Patent WO03004704
GAGNCCC
>AX765474.1 Sequence 944 from Patent WO03004704
CCGNCCC
>AX765461.1 Sequence 931 from Patent WO03004704
CCGNAGG
>AX765447.1 Sequence 917 from Patent WO03004704
AGGNCCC
>AX765433.1 Sequence 903 from Patent WO03004704
CCANCCC
>AX765432.1 Sequence 902 from Patent WO03004704
CGCNGGA
>AX765421.1 Sequence 891 from Patent WO03004704
GCGNCCA
>AX765386.1 Sequence 856 from Patent WO03004704
CCCNGCC
>AX765337.1 Sequence 807 from Patent WO03004704
CCCNCGG
>AX765321.1 Sequence 791 from Patent WO03004704
CGGNTGC
>AX765256.1 Sequence 726 from Patent WO03004704
AGCNGCC
>AX765227.1 Sequence 697 from Patent WO03004704
GGCNCCC
>AX765184.1 Sequence 654 from Patent WO03004704
AGCNCCC
>AX765171.1 Sequence 641 from Patent WO03004704
CCCNCGC
>AX765125.1 Sequence 595 from Patent WO03004704
GCANCGC
>AX765106.1 Sequence 576 from Patent WO03004704
CCCNACC
>AX765105.1 Sequence 575 from Patent WO03004704
CCGNCGG
>AX765099.1 Sequence 569 from Patent WO03004704
CGCNGCC
>AX765090.1 Sequence 560 from Patent WO03004704
CTGNCCC
>AX765084.1 Sequence 554 from Patent WO03004704
AGGNCGC
>AX765082.1 Sequence 552 from Patent WO03004704
CGGNGGC
>AX765056.1 Sequence 526 from Patent WO03004704
GCGNACC
>AX765049.1 Sequence 519 from Patent WO03004704
CGGNCCC
>AX765040.1 Sequence 510 from Patent WO03004704
GCCNCGC
>AX765012.1 Sequence 482 from Patent WO03004704
AGCNGCG
>AX765002.1 Sequence 472 from Patent WO03004704
CCCNCCG
>AX764999.1 Sequence 469 from Patent WO03004704
CGCNGGC
>AX764991.1 Sequence 461 from Patent WO03004704
CCANCGG
>AX764986.1 Sequence 456 from Patent WO03004704
CCGNCAG
>AX764971.1 Sequence 441 from Patent WO03004704
CAGNGGG
>AX764957.1 Sequence 427 from Patent WO03004704
CGGNGCA
>AX764939.1 Sequence 409 from Patent WO03004704
GGANCCC
>AX764929.1 Sequence 399 from Patent WO03004704
CGGNGCC
>AX764905.1 Sequence 375 from Patent WO03004704
CCCNCCC
>AX764902.1 Sequence 372 from Patent WO03004704
CGCNGAC
>AX764886.1 Sequence 356 from Patent WO03004704
CCCNGCG
>AX741063.1 Sequence 11 from Patent WO03026688
TAACGAT
>AX741062.1 Sequence 10 from Patent WO03026688
TAACGCT
>AX741061.1 Sequence 9 from Patent WO03026688
TAGCGTT
>AX741060.1 Sequence 8 from Patent WO03026688
TGACGTT
>AX722298.1 Sequence 2 from Patent WO03025169
CACCTGC
>AX718185.1 Sequence 55 from Patent WO02103008
CACNGAA
>AX711253.1 Sequence 20 from Patent WO03016343
CCYNCCY
>AX710027.1 Sequence 9 from Patent EP1288313
GCTCTGS
>AX710026.1 Sequence 8 from Patent EP1288313
GCTCTGT
>AX710025.1 Sequence 7 from Patent EP1288313
GACTGAD
>AX710024.1 Sequence 6 from Patent EP1288313
GACTGAA
>AX709475.1 Sequence 12 from Patent WO02098443
GAACAAG
>AX683649.1 Sequence 51 from Patent WO03006659
TTGTCTC
>AX683648.1 Sequence 50 from Patent WO03006659
CTGTCAC
>AX683623.1 Sequence 25 from Patent WO03006659
CTGTCAC
>AX683622.1 Sequence 24 from Patent WO03006659
YTGTCNC
>AX683621.1 Sequence 23 from Patent WO03006659
BTGTCNC
>AX675006.1 Sequence 133 from Patent WO03005034
GTTTCTT
>AX671485.1 Sequence 9 from Patent WO03004045
GTTTCTT
>AX664098.1 Sequence 1 from Patent WO0244425
ATGCCTG
>AX658892.1 Sequence 16 from Patent WO02102855
GGTCACC
>AX642160.1 Sequence 12 from Patent WO0246435
AAGATCT
>AX574432.1 Sequence 4 from Patent WO02068629
AGGAGGT
>AX573623.1 Sequence 33 from Patent WO02079467
CTGTTTC
>AX573611.1 Sequence 21 from Patent WO02079467
TCCTCTC
>AX556257.1 Sequence 2 from Patent WO0242447
TGACTCA
>AX552612.1 Sequence 28 from Patent WO02074963
TCTAGGC
>AX552611.1 Sequence 27 from Patent WO02074963
TCATAGG
>AX552605.1 Sequence 21 from Patent WO02074963
TCATAGG
>AX552604.1 Sequence 20 from Patent WO02074963
TCCTAGA
>AX552603.1 Sequence 19 from Patent WO02074963
TGTTGGA
>AX547495.1 Sequence 634 from Patent WO02053141
AACGTTG
>AX547494.1 Sequence 633 from Patent WO02053141
TCAACGT
>AX547474.1 Sequence 613 from Patent WO02053141
CAACGTT
>AX504837.1 Sequence 473 from Patent WO0233089
ANNATGG
>AX497970.1 Sequence 3 from Patent WO02057302
TAAAAAN
>BD135594.1 Observation alley for expression of cancer-related gene
GCGAAGC
>BD090937.1 Method for quantifying DNA binding activity of DNA binding proteins
TATAAAA
>BD087527.1 Self-assembling microelectronic integration system capable of designating self address, compartment device, mechanism, method and operation for molecular biological analysis and diagnosis
ACAACGC
>BD087526.1 Self-assembling microelectronic integration system capable of designating self address, compartment device, mechanism, method and operation for molecular biological analysis and diagnosis
ACACCGC
>BD084779.1 Human nerve growth factor exon 1 and exon 3 promoters
AGGATGT
>BD084777.1 Human nerve growth factor exon 1 and exon 3 promoters
CTGAGGA
>BD084775.1 Human nerve growth factor exon 1 and exon 3 promoters
ATGCAAT
>BD084770.1 Human nerve growth factor exon 1 and exon 3 promoters
CTCTCTT
>BD084768.1 Human nerve growth factor exon 1 and exon 3 promoters
AACCAAT
>BD084751.1 Human nerve growth factor exon 1 and exon 3 promoters
TGCRCRC
>BD084748.1 Human nerve growth factor exon 1 and exon 3 promoters
AGAAATG
>BD084747.1 Human nerve growth factor exon 1 and exon 3 promoters
TRTTTGY
>BD084736.1 Human nerve growth factor exon 1 and exon 3 promoters
WTCGTCA
>BD084734.1 Human nerve growth factor exon 1 and exon 3 promoters
TATAWAW
>BD084726.1 Human nerve growth factor exon 1 and exon 3 promoters
GGAAGTG
>BD084718.1 Human nerve growth factor exon 1 and exon 3 promoters
TKASTMA
>BD080740.1 Presenilin-1 gene promoter
GGGCGGG
>BD080524.1 Ribonucleoside-derivative and method for preparing the same
CCCCGAG
>BD078106.1 Discriminative ligand activation of estrogen receptors ER-alpha and ER-beta at AP1-site
TGASTCA
>BD073136.1 Antisense oligonucleotide inhibition of RAS
CCGACGG
>BD069968.1 Use of nucleic acids containing unmethylated CPG dinucleotide in the treatment of LPS-associated disorders
CGACGTT
>BD069928.1 Use of nucleic acids containing unmethylated CPG dinucleotide in the treatment of LPS-associated disorders
TGTCGTT
>BD063221.1 Prokaryotic two-hybrid system
CAAAAAT
>BD023708.1 Method for detecting and inhibiting RNA component of telomerase
GCTCTAG
>BD023224.1 Radiolabeled DNA oligonucleotide, method for preparing the same and therapeutic use thereof
GGGGCAT
>BD017138.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
TNNATGN
>BD017137.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
CNNATGN
>BD017136.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
GNNATGN
>BD017135.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
ANNATGN
>BD017134.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
NNNATGC
>BD017133.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
NNNATGT
>BD017132.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
NNNATGA
>BD017131.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
NNNATGG
>BD017130.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
TNNATGC
>BD017129.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
TNNATGT
>BD017128.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
CNNATGC
>BD017127.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
TNNATGA
>BD017126.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
CNNATGT
>BD017125.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
CNNATGA
>BD017124.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
TNNATGG
>BD017123.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
GNNATGT
>BD017122.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
CNNATGG
>BD017121.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
GNNATGC
>BD017120.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
GNNATGA
>BD017119.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
ANNATGC
>BD017118.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
ANNATGT
>BD017117.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
ANNATGA
>BD017116.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
GNNATGG
>BD017115.1 Device for correcting frame shift errors and method therefor and computer-readable medium that embodies program for carrying out said method
ANNATGG
>BD013732.1 Method of discriminating rice sample varieties
TGCCTCG
>BD013729.1 Method of discriminating rice sample varieties
GTCGTTC
>BD013417.1 Transcriptional factor
AATGCAA
>BD013416.1 Transcriptional factor
TATGCAA
>AX481358.1 Sequence 5 from Patent EP1225232
GTAAGCG
>AX481357.1 Sequence 4 from Patent EP1225232
GTAAGTG
>E65215.1 Method for analyzing oligonucleotide
TNNTGCA
>E65213.1 Method for analyzing oligonucleotide
CGAATAC
>AX465337.1 Sequence 5 from Patent WO0211761
TGTCGCT
>AX465336.1 Sequence 4 from Patent WO0211761
TGTCGTT
>AX465333.1 Sequence 1 from Patent WO0211761
TGACGTT
>AX464722.1 Sequence 14 from Patent WO0210458
GAATTCG
>AX456386.1 Sequence 244 from Patent WO0216944
TGASTMA
>AX455643.1 Sequence 120 from Patent WO0222809
TGTCGTT
>AX455642.1 Sequence 119 from Patent WO0222809
TGTCGCT
>AX455562.1 Sequence 39 from Patent WO0222809
CAACGTT
>AX454052.1 Sequence 2 from Patent WO0202605
ACTTGCT
>AX454051.1 Sequence 1 from Patent WO0202605
ACTGGTT
>AX451625.1 Sequence 3 from Patent WO0224899
TACTAAC
>AX428531.1 Sequence 3 from Patent WO0212514
CTAGTTC
>AX428530.1 Sequence 2 from Patent WO0212514
TATATAA
>AX412951.1 Sequence 715 from Patent WO0222675
GNCCAAA
>AX379594.1 Sequence 4 from Patent WO0196391
ACCATGG
>AX376682.1 Sequence 33 from Patent WO0212517
ACGTGGC
>AX376681.1 Sequence 32 from Patent WO0212517
CAAACAC
>AX376661.1 Sequence 12 from Patent WO0212517
CNAACAC
>AX364583.1 Sequence 1 from Patent WO0208388
CAGACAG
>AX361900.1 Sequence 293 from Patent WO0208267
TGCAATC
>AX361824.1 Sequence 217 from Patent WO0208267
TGCAATC
>AX359004.1 Sequence 11 from Patent WO0183737
TATAAAA
>AX358067.1 Sequence 13 from Patent WO0187957
GGCATGC
>BD010771.1 Specific gene activation by chimeric Gal4 transcription factors in stable transgenic plants
TAACACA
>BD010005.1 Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and splice variants thereof
TATTTAA
>BD009994.1 Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and splice variants thereof
RNNATGR
>BD009993.1 Human mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and splice variants thereof
AAATAAA
>BD006242.1 Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
CCGACGG
>BD004841.1 Method for manufucturing amplicons, detecting method thereby
ATCTGTT
>E52176.1 Novel MITE-like factor
AATGCAA
>E52175.1 Novel MITE-like factor
TATGCAA
>E64763.1 Chemically synthesized artificial promoter for realizing high-level expression of introduced gene and method for synthesizing the same
ANNNNCA
>E54573.1 Herpesvirus recombinant poxvirus vaccine
CTAATAG
>BD000170.1 Signal amplification of DNA probe
CGATTGC
>BD000169.1 Signal amplification of DNA probe
GCAATCG
>AX356057.1 Sequence 2 from Patent WO0179549
TTTTTVV
>AX351054.1 Sequence 6 from Patent WO0194600
GAGTTTT
>AX277463.1 Sequence 3 from Patent WO0160998
TCCTTCC
>AX277462.1 Sequence 2 from Patent WO0160998
GCCATCC
>AX268759.1 Sequence 7 from Patent WO0174342
AGTATGA
>AX268755.1 Sequence 3 from Patent WO0174342
AGTATGA
>AX287027.1 Sequence 19 from Patent WO0181607
TAATAAA
>AX235315.1 Sequence 17 from Patent WO0162967
CATTCCT
>AX235303.1 Sequence 5 from Patent WO0162967
TRTTTGY
>AX235087.1 Sequence 44 from Patent WO0163540
AAAAGAA
>AX211970.1 Sequence 13 from Patent WO0159453
CATTCAN
>AX211969.1 Sequence 12 from Patent WO0159453
GGTGNAT
>AX211968.1 Sequence 11 from Patent WO0159453
GGTNAAT
>AX211967.1 Sequence 10 from Patent WO0159453
ATTCACC
>AX211966.1 Sequence 9 from Patent WO0159453
NGTGAAT
>AX211965.1 Sequence 8 from Patent WO0159453
NTGAATG
>AX211964.1 Sequence 7 from Patent WO0159453
NGAATGC
>AX211690.1 Sequence 20 from Patent WO0159138
ACGACTT
>AX207280.1 Sequence 5 from Patent WO0155371
TGACTCA
>AX206858.1 Sequence 4 from Patent WO0155391
AACATGG
>AX203149.1 Sequence 2 from Patent WO0153529
TACTAAC
>AX175301.1 Sequence 65 from Patent WO0144465
GGGTGGT
>AX175300.1 Sequence 64 from Patent WO0144465
TGGGTGG
>AX175299.1 Sequence 63 from Patent WO0144465
GGGTGGG
>AX175298.1 Sequence 62 from Patent WO0144465
GGGGTGG
>AX166333.1 Sequence 31 from Patent WO0123562
CTCGAGA
>AX166332.1 Sequence 30 from Patent WO0123562
GGAGACA
>AX166331.1 Sequence 29 from Patent WO0123562
AGATATC
>AX166330.1 Sequence 28 from Patent WO0123562
AACCTCA
>AX156050.1 Sequence 293 from Patent WO0140474
TGCAATC
>AX155974.1 Sequence 217 from Patent WO0140474
TGCAATC
>AX155742.1 Sequence 154 from Patent WO0140279
GCTTAGA
>AX155741.1 Sequence 153 from Patent WO0140279
GGCTTAG
>AX155740.1 Sequence 152 from Patent WO0140279
TGGCTTA
>AX155739.1 Sequence 151 from Patent WO0140279
TTGGCTT
>AX155738.1 Sequence 150 from Patent WO0140279
TTTGGCT
>AX155737.1 Sequence 149 from Patent WO0140279
TTTTGGC
>AX155736.1 Sequence 148 from Patent WO0140279
TTTTTGG
>AX155735.1 Sequence 147 from Patent WO0140279
CTTTTTG
>AX155734.1 Sequence 146 from Patent WO0140279
CCTTTTT
>AX155733.1 Sequence 145 from Patent WO0140279
GCCTTTT
>AX155732.1 Sequence 144 from Patent WO0140279
GGCCTTT
>AX155731.1 Sequence 143 from Patent WO0140279
TGGCCTT
>AX155730.1 Sequence 142 from Patent WO0140279
ATGGCCT
>AX155729.1 Sequence 141 from Patent WO0140279
TATGGCC
>AX155728.1 Sequence 140 from Patent WO0140279
ATATGGC
>AX155727.1 Sequence 139 from Patent WO0140279
CATATGG
>AX155726.1 Sequence 138 from Patent WO0140279
CCATATG
>AX155725.1 Sequence 137 from Patent WO0140279
GCCATAT
>AX155724.1 Sequence 136 from Patent WO0140279
TGCCATA
>AX155723.1 Sequence 135 from Patent WO0140279
TTGCCAT
>AX155722.1 Sequence 134 from Patent WO0140279
TTTGCCA
>AX155721.1 Sequence 133 from Patent WO0140279
CTTTGCC
>AX155720.1 Sequence 132 from Patent WO0140279
ACTTTGC
>AX155719.1 Sequence 131 from Patent WO0140279
AACTTTG
>AX155718.1 Sequence 130 from Patent WO0140279
CAACTTT
>AX155717.1 Sequence 129 from Patent WO0140279
ACAACTT
>AX155716.1 Sequence 128 from Patent WO0140279
AACAACT
>AX155715.1 Sequence 127 from Patent WO0140279
GAACAAC
>AX155714.1 Sequence 126 from Patent WO0140279
AGAACAA
>AX155713.1 Sequence 125 from Patent WO0140279
TAGAACA
>AX138240.1 Sequence 23 from Patent EP1069187
GGGGCCA
>AX107949.1 Sequence 6 from Patent WO0123559
TGTGGTT
>AX105218.1 Sequence 117 from Patent WO0122990
TGTCGYT
>AX105156.1 Sequence 55 from Patent WO0122990
CAACGTT
>AX104442.1 Sequence 634 from Patent WO0122972
AACGTTG
>AX104441.1 Sequence 633 from Patent WO0122972
TCAACGT
>AX104421.1 Sequence 613 from Patent WO0122972
CAACGTT
>AX103589.1 Sequence 154 from Patent EP1104811
GCTTAGA
>AX103588.1 Sequence 153 from Patent EP1104811
GGCTTAG
>AX103587.1 Sequence 152 from Patent EP1104811
TGGCTTA
>AX103586.1 Sequence 151 from Patent EP1104811
TTGGCTT
>AX103585.1 Sequence 150 from Patent EP1104811
TTTGGCT
>AX103584.1 Sequence 149 from Patent EP1104811
TTTTGGC
>AX103583.1 Sequence 148 from Patent EP1104811
TTTTTGG
>AX103582.1 Sequence 147 from Patent EP1104811
CTTTTTG
>AX103581.1 Sequence 146 from Patent EP1104811
CCTTTTT
>AX103580.1 Sequence 145 from Patent EP1104811
GCCTTTT
>AX103579.1 Sequence 144 from Patent EP1104811
GGCCTTT
>AX103578.1 Sequence 143 from Patent EP1104811
TGGCCTT
>AX103577.1 Sequence 142 from Patent EP1104811
ATGGCCT
>AX103576.1 Sequence 141 from Patent EP1104811
TATGGCC
>AX103575.1 Sequence 140 from Patent EP1104811
ATATGGC
>AX103574.1 Sequence 139 from Patent EP1104811
CATATGG
>AX103573.1 Sequence 138 from Patent EP1104811
CCATATG
>AX103572.1 Sequence 137 from Patent EP1104811
GCCATAT
>AX103571.1 Sequence 136 from Patent EP1104811
TGCCATA
>AX103570.1 Sequence 135 from Patent EP1104811
TTGCCAT
>AX103569.1 Sequence 134 from Patent EP1104811
TTTGCCA
>AX103568.1 Sequence 133 from Patent EP1104811
CTTTGCC
>AX103567.1 Sequence 132 from Patent EP1104811
ACTTTGC
>AX103566.1 Sequence 131 from Patent EP1104811
AACTTTG
>AX103565.1 Sequence 130 from Patent EP1104811
CAACTTT
>AX103564.1 Sequence 129 from Patent EP1104811
ACAACTT
>AX103563.1 Sequence 128 from Patent EP1104811
AACAACT
>AX103562.1 Sequence 127 from Patent EP1104811
GAACAAC
>AX103561.1 Sequence 126 from Patent EP1104811
AGAACAA
>AX103560.1 Sequence 125 from Patent EP1104811
TAGAACA
>AX101010.1 Sequence 4 from Patent WO0121824
CGGTCCG
>AX101009.1 Sequence 3 from Patent WO0121824
CGGACCG
>AX100027.1 Sequence 21 from Patent WO0120035
GGAATTC
>AX098548.1 Sequence 6 from Patent WO0119792
AGTTACT
>AX098546.1 Sequence 4 from Patent WO0119792
AGGAAAA
>AX088611.1 Sequence 176 from Patent WO0114536
TTCACAG
>AX083842.1 Sequence 2 from Patent WO0112852
TAGTTCT
>AX078794.1 Sequence 9 from Patent WO0105986
AATGCAA
>AX078793.1 Sequence 8 from Patent WO0105986
TATGCAA
>AX074491.1 Sequence 51 from Patent WO0104319
GGGGCCA
>AX073579.1 Sequence 1 from Patent WO0104320
ACTGGTT
>AX069172.1 Sequence 5 from Patent WO0102576
GTAAACG
>AX069171.1 Sequence 4 from Patent WO0102576
GTAAACA
>AX063660.1 Sequence 44 from Patent WO0100817
TTCGCGC
>AX063646.1 Sequence 30 from Patent WO0100817
TGACTCA
>AX063643.1 Sequence 27 from Patent WO0100817
TGAGTCA
>AX063640.1 Sequence 24 from Patent WO0100817
AAGCGCA
>AX062098.1 Sequence 70 from Patent WO0100846
GGTAGGA
>AX062095.1 Sequence 67 from Patent WO0100846
GAAGGAG
>AX062090.1 Sequence 62 from Patent WO0100846
AAGGAAG
>AX040417.1 Sequence 2 from Patent WO0063440
CCTTAAG
>AX036340.1 Sequence 2 from Patent DE19915141
CTGANGA
>AX022048.1 Sequence 2 from Patent EP0960940
GTGGTCC
>AX028177.1 Sequence 2 from Patent WO0038674
TATTTAT
>AX027917.1 Sequence 2 from Patent WO0039314
TATTTAT
>AX025601.1 Sequence 1 from Patent WO0029592
TTTGACC
>AX022265.1 Sequence 44 from Patent EP0948597
TATTTAA
>AX022250.1 Sequence 29 from Patent EP0948597
RNNATGR
>AX022249.1 Sequence 28 from Patent EP0948597
AAATAAA
>AX021104.1 Sequence 39 from Patent WO9931260
CAATTAG
>AX021103.1 Sequence 38 from Patent WO9931260
CAATTAG
>AX021102.1 Sequence 37 from Patent WO9931260
CAATTAG
>AX021101.1 Sequence 36 from Patent WO9931260
CAATTAG
>AX021081.1 Sequence 16 from Patent WO9931260
CTTAATG
>AX021080.1 Sequence 15 from Patent WO9931260
CTTAATG
>AX021079.1 Sequence 14 from Patent WO9931260
CTTAATG
>AX010331.1 Sequence 2 from Patent WO9960007
TTCTATT
>AX010330.1 Sequence 1 from Patent WO9960007
TTCCAGT
>A97997.1 Sequence 27 from Patent WO9914366
CCTGAGG
>A97998.1 Sequence 28 from Patent WO9914366
CCCAGGC
>A93844.1 Sequence 4 from Patent EP0790313
TAGGAAA
>A85266.1 Sequence 5 from Patent WO9840506
ACCATGG
>A82657.1 Sequence 2 from Patent WO9855646
TAGTCCC
>A75780.1 Sequence 49 from Patent WO9322437
TTATTAT
